This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in c19_div01 |
1. Magnesio: revelancia na fisiologia e clinica. 1a Parte: Homeostasia e perturbacoes no metabolismo do magnesio. | *11155489* 11155489 | ||
PMC1751095 2. Does magnesium sulphate have a role in the management of paediatric status asthmaticus? | *11970943* 11970943 | ||
3. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. | *11762939* 11762939 | ||
4. Inflammatory response following acute magnesium deficiency in the rat. | *10838183* 10838183 | ||
5. Management of life-threatening autonomic hyper-reflexia using magnesium sulphate in a patient with a high spinal cord injury in the intensive care unit. | *11990279* 11990279 | ||
PMC1725934 6. The role of magnesium in the emergency department. | *12101132* 12101132 | ||
7. Hypomagnesaemia in chronic, stable asthmatics: prevalence, correlation with severity and hospitalization. | *11028655* 11028655 | ||
8. Magnesium levels in plasma and erythrocytes before and after histamine challenge. | *11106202* 11106202 | ||
9. Reduced intracellular magnesium concentrations in asthmatic patients. | *10836320* 10836320 | ||
PMC2326960 10. Simple chemicals can induce maturation and apoptosis of dendritic cells. | *10594678* 10594678 | ||
11. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. | *12154098* 12154098 | ||
12. Fas-induced B cell apoptosis requires an increase in free cytosolic magnesium as an early event. | *10066762* 10066762 | ||
13. Apoptogenic ganglioside GD3 directly induces the mitochondrial permeability transition. | *10438487* 10438487 | ||
14. Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3. | *10187863* 10187863 | ||
15. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. | *10620073* 10620073 | ||
PMC2190074 16. Fibrinogen/fibrin on the surface of macrophages: detection, distribution, binding requirements, and possible role in macrophage adherence phenomena. | *1104745* 1104745 | ||
17. Enhanced production of IL-1beta and IL-6 following endotoxin challenge in rats with dietary magnesium deficiency. | *11346186* 11346186 | ||
18. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. | *10231464* 10231464 | ||
PMC1781659 19. Effects of the cationic protein poly-L-arginine on airway epithelial cells in vitro. | *12137242* 12137242 | ||
20. Diet and asthma. | *11059944* 11059944 | ||
PMC59508 21. Chronic obstructive pulmonary disease, asthma and protective effects of food intake: from hypothesis to evidence? | *11686892* 11686892 | ||
PMC1745426 22. Dietary antioxidants and magnesium in type 1 brittle asthma: a case control study. | *10325914* 10325914 | ||
23. Does exposure to magnesium sulfate in utero decrease the risk of necrotizing enterocolitis in premature infants? | *11167206* 11167206 | ||
24. Dietary micronutrients/antioxidants and their relationship with bronchial asthma severity. | *11167351* 11167351 | ||
25. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. | *10426331* 10426331 | ||
26. Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor alpha. | *10617950* 10617950 | ||
27. Efficacy of magnesium sulfate in acute adult asthma: a meta-analysis of randomized trials. | *10750936* 10750936 | ||
28. Dietary magnesium, potassium, sodium, and children's lung function. | *11790675* 11790675 | ||
29. Intravenous magnesium sulfate treatment in a child with status asthmaticus. | *10365726* 10365726 | ||
30. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. | *11273867* 11273867 | ||
31. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. | *10329963* 10329963 | ||
32. Sufficient dosing of intravenous magnesium for severe asthma. | *11326199* 11326199 | ||
33. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. | *10969218* 10969218 | ||
34. A randomized trial of magnesium in the emergency department treatment of children with asthma. | *11097697* 11097697 | ||
35. Management of acute, severe asthma in children. | *12086560* 12086560 | ||
36. Analysis of antioxidant enzyme activity and magnesium level in chronic obstructive pulmonary disease (COPD). | *11977322* 11977322 | ||
37. Serum magnesium levels in asthmatic children during and between exacerbations. | *11177094* 11177094 | ||
38. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. | *11030848* 11030848 | ||
39. Oral magnesium supplementation induces favorable antiatherogenic changes in ApoE-deficient mice. | *11348887* 11348887 | ||
40. Progressionsverlauf experimentell ausgeloster arteriosklerotischer Gefasswandveranderungen nach Behandlung mit Magnesiumorotat. | *11190771* 11190771 | ||
41. Calcium and lipoprotein lipase synergistically enhance the binding and uptake of native and oxidized LDL in mouse peritoneal macrophages. | *10856527* 10856527 | ||
42. Role of plasma membrane coenzyme Q on the regulation of apoptosis. | *10416029* 10416029 | ||
43. Ion movements in cell death: from protection to execution. | *12415738* 12415738 | ||
44. Accelerated thymus involution in magnesium-deficient rats is related to enhanced apoptosis and sensitivity to oxidative stress. | *10615213* 10615213 | ||
45. The thymus: a barometer of malnutrition. | *10615206* 10615206 | ||
46. Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. | *12419529* 12419529 | ||
47. Expression of Bax and Bcl-2 proteins during hypoxia in cerebral cortical neuronal nuclei of newborn piglets: effect of administration of magnesium sulfate. | *11368946* 11368946 | ||
48. Pathophysiology of perinatal brain damage. | *10525170* 10525170 | ||
49. Magnesium deficiency: effect on bone and mineral metabolism in the mouse. | *12370796* 12370796 | ||
50. Role of serum components in the binding and phagocytosis of oxidatively damaged erythrocytes by autologous mouse macrophages. | *11706999* 11706999 | ||
51. Ceramide and sphingomyelinases in the regulation of stress responses. | *11001568* 11001568 | ||
52. Reduced intracellular Mg concentrations in patients with acute asthma. | *12527611* 12527611 | ||
53. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. | *12171821* 12171821 | ||
54. Electrolyte disturbances in patients with chronic, stable asthma: effect of therapy. | *11502640* 11502640 | ||
55. Treatment of acute asthma. A new look at the old and at the new. | *10907594* 10907594 | ||
56. Magnesium concentration in plasma, leukocytes and urine of children with intermittent asthma. | *11580927* 11580927 | ||
57. Magnesium. An update on physiological, clinical and analytical aspects. | *10727669* 10727669 | ||
58. The relationship of eosinophil granule proteins to ions in the sputum of patients with cystic fibrosis. | *11122216* 11122216 | ||
59. Intravenous magnesium sulfate for bronchial hyperreactivity: a randomized, controlled, double-blind study. | *11372005* 11372005 | ||
60. Pharmacologic treatment of the adult hospitalized asthma patient. | *11413904* 11413904 | ||
61. Magnesium regulates hypoxia-stimulated apoptosis in the human placenta. | *10731470* 10731470 | ||
62. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. | *10796650* 10796650 | ||
63. Hypomagnesemic disorders. | *11219227* 11219227 | ||
64. Adenosine triphosphate-magnesium dichloride during hyperdynamic porcine endotoxemia: effects on hepatosplanchnic oxygen exchange and metabolism. | *12163801* 12163801 | ||
65. Divalent cations and bronchodilation in asthma. | *10397201* 10397201 | ||
66. Nutritional issues and asthma. | *10608431* 10608431 | ||
67. Drinking water composition and childhood-onset Type 1 diabetes mellitus in Devon and Cornwall, England. | *11606168* 11606168 | ||
68. Diet and obstructive lung diseases. | *12192737* 12192737 | ||
69. Intravenous magnesium sulphate in the management of moderate to severe acute asthmatic children nonresponding to conventional therapy. | *10622383* 10622383 | ||
70. Changes in elemental content during apoptotic cell death studied by electron probe X-ray microanalysis. | *10585268* 10585268 | ||
71. Retinal changes in magnesium-deficient rats. | *11133179* 11133179 | ||
72. Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. | *11440826* 11440826 | ||
73. Magnesium in cell proliferation and differentiation. | *10430554* 10430554 | ||
74. Increased adenosine triphosphatase activity in platelets of asthmatic children. | *123227* 123227 | ||
75. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). | *10567665* 10567665 | ||
76. Adenosine triphosphate-magnesium chloride: relevance for intensive care. | *12528016* 12528016 | ||
77. Magnesium as a relaxing factor of airway smooth muscles. | *11693841* 11693841 | ||
78. Assessment of magnesium status in patients with bronchial asthma. | *11011755* 11011755 | ||
79. Magnesium sulfate administered via continuous intravenous infusion in pediatric patients with refractory wheezing. | *12501154* 12501154 | ||
80. An investigation of hypomagnesemia among ambulatory urban African Americans. | *10496643* 10496643 | ||
81. How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. | *10081503* 10081503 | ||
82. Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells. | *11451199* 11451199 | ||
83. Perinatal brain damage: underlying mechanisms and neuroprotective strategies. | *12445595* 12445595 | ||
84. Effect of long-term, postasphyxial administration of magnesium sulfate on immunostaining of microtubule-associated protein-2 and activated caspase-3 in 7-day-old rat brain. | *12113878* 12113878 | ||
85. Concentrations of copper, zinc and various elements in serum of patients with bronchial asthma. | *10941719* 10941719 | ||
86. Stress protein expression cDNA array study supports activation of neutrophils during acute magnesium deficiency in rats. | *12030422* 12030422 | ||
87. Low extracellular Mg2+ concentrations suppress phagocytosis in vitro by alveolar macrophages from rats. | *10761186* 10761186 | ||
88. Beneficial antithrombotic effects of the association of pharmacological oral magnesium therapy with aspirin in coronary heart disease patients. | *11153897* 11153897 | ||
89. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption. | *10612083* 10612083 | ||
90. Influence of age and K, Mg aspartate (Cardilan) on murine haemopoiesis. | *11080535* 11080535 | ||
91. The evaluation and management of acute, severe asthma. | *12428545* 12428545 | ||
92. The central role of magnesium deficiency in Tourette's syndrome: causal relationships between magnesium deficiency, altered biochemical pathways and symptoms relating to Tourette's syndrome and several reported comorbid conditions. | *11863398* 11863398 | ||
93. The Legionella pneumophila prp locus; required during infection of macrophages and amoebae. | *10588909* 10588909 | ||
94. Cell physiology of magnesium. | *12537986* 12537986 | ||
95. Role of magnesium in genomic stability. | *11295157* 11295157 | ||
96. Chronic low-Ca/Mg high-Al diet induces neuronal loss. | *12416556* 12416556 | ||
97. Physiologic concentrations of magnesium and placental apoptosis: prevention by antioxidants. | *11506852* 11506852 | ||
98. Drug therapy approaches in the treatment of acute severe asthma in hospitalised children. | *11513282* 11513282 | ||
99. Acute asthma in the pediatric emergency department. | *10629678* 10629678 | ||
100. Nitric oxide further attenuates pulmonary hypertension in magnesium-treated piglets. | *12421268* 12421268 | ||
101. Pharmacologic therapy of persistent pulmonary hypertension of the newborn. | *11316514* 11316514 | ||
102. Prehospital asthma management. | *12540142* 12540142 | ||
103. Acute renal failure and metabolic disturbances in the short bowel syndrome. | *11834771* 11834771 | ||
104. Sphingomyelinases in cell regulation. | *10024495* 10024495 | ||
105. Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis. | *11442313* 11442313 | ||
106. Calcium uptake by sarcoplasmic reticulum is impaired during the hypodynamic phase of sepsis in the rat heart. | *11198357* 11198357 | ||
107. Magnesium: its proven and potential clinical significance. | *11811859* 11811859 | ||
108. Magnesium for the next millennium. | *10586828* 10586828 | ||
109. Lethal iatrogenic hypermagnesemia. | *12174756* 12174756 | ||
110. Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism. | *12364856* 12364856 | ||
111. "Pseudoseptic" pseudogout associated with hypomagnesemia in liver transplant patients. | *11292305* 11292305 | ||
112. Biochemical changes induced by hypomagnesaemia in lactating cows and ewes. | *11890174* 11890174 | ||
113. The 'crashing asthmatic.'. | *12643359* 12643359 | ||
114. An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma. | *15354679* 15354679 | ||
115. Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype. | *12860567* 12860567 | ||
116. Intravenous magnesium sulphate and salbutamol for asthma. | *14725539* 14725539 | ||
117. A novel role for magnesium? | *14705710* 14705710 | ||
118. Intravenous magnesium therapy in critically ill patients. | *1489060* 1489060 | ||
PMC3668433 119. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery. | *12643408* 12643408 | ||
PMC1574050 120. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages. | *12970084* 12970084 | ||
PMC2896314 121. Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. | *14576195* 14576195 | ||
PMC1065104 122. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. | *15693962* 15693962 | ||
PMC1726407 123. Best evidence topic report. Nebulised magnesium in asthma. | *15333539* 15333539 | ||
PMC1726289 124. Best evidence topic report. Intravenous magnesium in chronic obstructive pulmonary disease. | *14988352* 14988352 | ||
125. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. | *15329077* 15329077 | ||
PMC257286 126. Cytosolic free calcium is essential for immunoglobulin G-stimulated intracellular killing of Staphylococcus aureus by human monocytes. | *1322366* 1322366 | ||
127. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure. | *16177005* 16177005 | ||
128. Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects. | *15920100* 15920100 | ||
129. MAGNESIUM IN EPIDERMIS, DERMIS, AND WHOLE SKIN OF NORMAL AND ATOPIC SUBJECTS. | *14139558* 14139558 | ||
130. Magnesium depletion with hypo- or hyper- function of the biological clock may be involved in chronopathological forms of asthma. | *15945613* 15945613 | ||
131. Changes in gene expression in the lungs of Mg-deficient mice are related to an inflammatory process. | *15726901* 15726901 | ||
132. Enhanced release of IL-1beta and TNF-alpha following endotoxin challenge from rat alveolar macrophages cultured in low-mg(2+) medium. | *12892381* 12892381 | ||
133. Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: a randomized, placebo-controlled, double-blind study. | *14979636* 14979636 | ||
PMC1345685 134. Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages. | *16251362* 16251362 | ||
PMC420479 135. Short and long term treatment of asthma with intravenous nutrients. | *15144562* 15144562 | ||
PMC1266035 136. Immunolocalization of RANKL is increased and OPG decreased during dietary magnesium deficiency in the rat. | *16162295* 16162295 | ||
137. Apoptotic change in response to magnesium therapy after moderate diffuse axonal injury in rats. | *15515203* 15515203 | ||
138. Hypomagnesemia in acute and chronic care patient populations. | *1595603* 1595603 | ||
139. Expression of the nuclear factor-kappaB and proto-oncogenes c-fos and c-jun are induced by low extracellular Mg2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis, and stroke. | *12944025* 12944025 | ||
140. Endotoxin and myocardial failure: role of the myofibril and venous return. | *150799* 150799 | ||
141. Diet and asthma. | *15256393* 15256393 | ||
142. El magnesio: utilidad terapeutica en situaciones de urgencia. | *1504208* 1504208 | ||
143. The use of Marax inthe treatment of bronchial asthma. | *14457842* 14457842 | ||
144. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study. | *16254259* 16254259 | ||
145. A trial of nebulized magnesium sulfate to reverse bronchospasm in asthmatic patients. | *1514723* 1514723 | ||
146. Frequently nebulized beta-agonists for asthma: effects on serum electrolytes. | *1416329* 1416329 | ||
147. Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. | *16564020* 16564020 | ||
148. Transition metal-induced apoptosis in lymphocytes via hydroxyl radical generation, mitochondria dysfunction, and caspase-3 activation: an in vitro model for neurodegeneration. | *15163458* 15163458 | ||
149. Comparative effect of ion calcium and magnesium in the activation and infection of the murine macrophage by Leishmania major. | *15515964* 15515964 | ||
150. Should chronic obstructive pulmonary disease outpatients be routinely evaluated for trace elements? | *12907826* 12907826 | ||
151. Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse. | *14989640* 14989640 | ||
152. SEPARATION OF LYMPHOCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES ON GLASS COLUMNS, INCLUDING TISSUE CULTURE OBSERVATIONS. | *14161414* 14161414 | ||
153. Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat. | *15923157* 15923157 | ||
154. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. | *12944451* 12944451 | ||
155. Effects of magnesium sulfate on neuron apoptosis and expression of caspase-3, bax and bcl-2 after cerebral ischemia-reperfusion injury. | *14570617* 14570617 | ||
156. [Lipid metabolism and magnesium]. | *16272615* 16272615 | ||
157. [Magnesium and inflammation: lessons from animal models]. | *15692164* 15692164 | ||
158. The role of magnesium in traumatic brain injury. | *15577090* 15577090 | ||
159. Acute respiratory failure in pregnancy. | *1362144* 1362144 | ||
160. Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial. | *14519140* 14519140 | ||
161. Evaluation of magnesium in serum and urine in patients with pulmonary diseases. | *16329623* 16329623 | ||
162. Corneal changes in magnesium-deficient rats. | *12827051* 12827051 | ||
163. Microdialysis-evaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia. | *12794420* 12794420 | ||
164. Development of ionized hypomagnesemia is associated with higher mortality rates. | *12682476* 12682476 | ||
165. Intravenous magnesium. | *16602999* 16602999 | ||
166. Acute asthma and the life threatening episode. | *16599882* 16599882 | ||
167. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs. | *14680616* 14680616 | ||
168. Managing outpatient asthma exacerbations. | *12562559* 12562559 | ||
169. [Favorable results obtained with calcium and magnesium ions in asthmatiform bronchitis in children]. | *13884984* 13884984 | ||
170. [Asthma and magnesium. Etiopathogenetic considerations]. | *13842098* 13842098 | ||
171. Asma y magnesio. | *13261846* 13261846 | ||
172. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. | *15860239* 15860239 | ||
173. Plasma magnesium in adult asthmatics at the Lagos University Teaching Hospital, Nigeria. | *14640172* 14640172 | ||
174. Asthma evaluation and management. | *12793616* 12793616 | ||
175. Magnesium sulfate in prehospital care. | *15368985* 15368985 | ||
176. The critical role of magnesium ions in osteoclast-matrix interaction: implications for divalent cations in the study of osteoclastic adhesion molecules and bone resorption. | *1459174* 1459174 | ||
177. Possible roles of magnesium on the immune system. | *14506478* 14506478 | ||
178. Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. | *12814360* 12814360 | ||
179. Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. | *15769616* 15769616 | ||
180. Magnesium in clinical medicine. | *14977544* 14977544 | ||
181. Acute ventricular rate control in atrial fibrillation and atrial flutter. | *15336799* 15336799 | ||
182. The assessment and management of patients with acute asthma. | *16602397* 16602397 | ||
183. The use of magnesium sulfate in acute asthma: rapid uptake of evidence in North American emergency departments. | *16387584* 16387584 | ||
184. Amiloride increases neuronal damage after traumatic brain injury in rats. | *15466959* 15466959 | ||
185. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. | *15466951* 15466951 | ||
186. Hypomagnesemia due to beta 2-agonist use in bronchial asthma. | *1484002* 1484002 | ||
187. Metabolic effects of beta 2-agonists. | *1353501* 1353501 | ||
188. Use of magnesium sulfate for pediatric patients with acute asthma exacerbations. | *16205499* 16205499 | ||
189. Magnesium deficiency in critical illness. | *15665255* 15665255 | ||
190. Crystal structure of a free kappaB DNA: insights into DNA recognition by transcription factor NF-kappaB. | *15663934* 15663934 | ||
191. On the early emergence of reverse transcription: theoretical basis and experimental evidence. | *1282161* 1282161 | ||
192. A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats. | *15165363* 15165363 | ||
193. Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha. | *14704297* 14704297 | ||
194. Magnesium deficiency induces apoptosis in primary cultures of rat hepatocytes. | *12888628* 12888628 | ||
195. Amphotericin B nephrotoxicity in children. | *15218415* 15218415 | ||
196. N-methyl-D-aspartate receptor blockade inhibits cardiac inflammation in the Mg2+-deficient rat. | *15169828* 15169828 | ||
197. Improved solutions for peritoneal dialysis: physiological calcium solutions, osmotic agents and buffers. | *1405367* 1405367 | ||
198. Magnesium-deficient medium enhances NO production in alveolar macrophages isolated from rats. | *12570925* 12570925 | ||
199. Mechanisms underlying the enhanced elevation of IL-1beta and TNF-alpha mRNA levels following endotoxin challenge in rat alveolar macrophages cultured with low-Mg2+ medium. | *12635866* 12635866 | ||
200. Effects of a low extracellular magnesium concentration and endotoxin on IL-1beta and TNF-alpha release from, and mRNA levels in, isolated rat alveolar macrophages. | *12635865* 12635865 | ||
201. Oral magnesium supplementation improves fetal circulation. | *1467155* 1467155 | ||
202. Serum and mononuclear cell potassium, magnesium, sodium and calcium in pregnancy and labour and their relation to uterine muscle contraction. | *1467154* 1467154 | ||
203. Asthmatherapie mit Efrodal B; Ruckblick auf dreijahrige Erfahrungen. | *13464366* 13464366 | ||
204. Intestinal and cardiac inflammatory response shows enhanced endotoxin receptor (CD14) expression in magnesium deficiency. | *16180088* 16180088 | ||
205. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. | *1584207* 1584207 | ||
206. Heart sarcolemmal Ca2+ transport in endotoxin shock: I. Impairment of ATP-dependent Ca2+ transport. | *1322488* 1322488 | ||
207. Function and pharmacology of TRPM cation channels. | *15843919* 15843919 | ||
208. Effects of magnesium sulfate administration during hypoxia on Ca(2+) influx and IP(3) receptor modification in cerebral cortical neuronal nuclei of newborn piglets. | *16474998* 16474998 | ||
209. Low extracellular magnesium ions induce lipid peroxidation and activation of nuclear factor-kappa B in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes. | *12697280* 12697280 | ||
210. The possible relationship between keratoconus and magnesium deficiency. | *15649177* 15649177 | ||
211. Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism. | *16601920* 16601920 | ||
212. Genetics of hereditary disorders of magnesium homeostasis. | *14634861* 14634861 | ||
213. Iatrogenic acute hypermagnesemia after total parenteral nutrition infusion mimicking septic shock syndrome: two case reports. | *12837909* 12837909 | ||
214. Sole magnezu w leczeniu astmy oskrzelowej. | *1290984* 1290984 | ||
215. [Asthma and magnesium. Etiopathogenetic considerations]. | *13781180* 13781180 | ||
216. El cation magnesio en pediatria. | *13453252* 13453252 | ||
217. Esperienze cliniche sull'uso dell' A.M. 49 nell'asma bronchiale. | *14372796* 14372796 | ||
218. Ionized magnesium levels and the ratio of ionized calcium to magnesium in asthma patients before and after treatment with magnesium. | *16319040* 16319040 | ||
219. The role of the mitochondrion in trauma and shock. | *15489630* 15489630 | ||
220. Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats. | *16256834* 16256834 | ||
221. Dvukhvalentnye kationy soderzhimogo bronkhov v patogeneze i klinike bronkhial'noi astmy. | *1292136* 1292136 | ||
222. UN NOUVEAU TRAITEMENT DE L'ASTHME A L'AIDE D'UNE ASSOCIATION D'ANCIENS MEDICAMENTS. | *14083631* 14083631 | ||
223. Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation. | *12698095* 12698095 | ||
224. Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria. | *15249986* 15249986 | ||
225. [Intravenous therapy with magnesium sulfate]. | *13971871* 13971871 | ||
226. Adultes Still-Syndrom als Manifestation einer schweren Hypophosphatamie. Morbus Still--eine Storung des Energiestoffwechsels? | *12827405* 12827405 | ||
227. Therapeutic uses of magnesium. | *19621856* 19621856 | ||
PMC3753099 228. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. | *19593099* 19593099 | ||
229. Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues. | *19429813* 19429813 | ||
230. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol 2008; 294 (3): H1103-18 | *18192217* 18192217 | ||
PMC2801335 231. Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation. | *19741014* 19741014 | ||
232. Tratamiento de la crisis asmatica en pediatria. | *17949652* 17949652 | ||
233. Dose of magnesium sulphate for severe acute asthma. | *19681437* 19681437 | ||
234. The role of magnesium as an adjuvant during general anaesthesia. | *17042843* 17042843 | ||
PMC3671580 235. Cardioplegia and diazoxide modulate STAT3 activation and DNA binding. | *17888982* 17888982 | ||
236. Magnesium deficiency and its lack of association with asthma in Taiwanese elementary school children. | *17723998* 17723998 | ||
237. Cadmium-induced cytosolic Ca2+ elevation and subsequent apoptosis in renal tubular cells. | *19413654* 19413654 | ||
238. L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. | *19933511* 19933511 | ||
PMC2014691 239. Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. | *17031385* 17031385 | ||
240. Hypomagnesemia is a risk factor for nonrecovery of renal function and mortality in AIDS patients with acute kidney injury. | *20401440* 20401440 | ||
PMC1855626 241. Magnesium metabolism and its disorders. | *18568054* 18568054 | ||
242. Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia. | *19010875* 19010875 | ||
PMC2564084 243. Comparison of nebulised magnesium sulphate and salbutamol combined with salbutamol alone in the treatment of acute bronchial asthma: a randomised study. | *16627836* 16627836 | ||
PMC2831925 244. Case report: analytical electron microscopy of lung granulomas associated with exposure to coating materials carried by glass wool fibers. | *20123612* 20123612 | ||
245. Effect of magnesium ions on the activity of the cytosolic NADH/cytochrome c electron transport system. | *19016854* 19016854 | ||
246. Low magnesium concentration in erythrocytes of children with acute asthma. | *17237571* 17237571 | ||
PMC2707206 247. Magnesium deficiency causes loss of response to intermittent hypoxia in paraganglion cells. | *19433582* 19433582 | ||
PMC6649164 248. Magnesium and calcium in exhaled breath condensate of children with asthma and gastroesophageal reflux disease. | *19140217* 19140217 | ||
249. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. | *18768827* 18768827 | ||
250. Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages. | *19017980* 19017980 | ||
251. The biochemical function of Mg(2)+ in insulin secretion, insulin signal transduction and insulin resistance. | *20228013* 20228013 | ||
252. Phagocyte priming by low magnesium status: input to the enhanced inflammatory and oxidative stress responses. | *20228008* 20228008 | ||
253. Magnesium homeostasis and aging. | *20228001* 20228001 | ||
254. Effects of long-term dietary intake of magnesium on oxidative stress, apoptosis and ageing in rat liver. | *18705541* 18705541 | ||
255. Magnesium homeostasis and alcohol consumption. | *19271417* 19271417 | ||
256. Chronic dietary Mg2+ deficiency induces cardiac apoptosis in the rat heart. | *17972464* 17972464 | ||
257. Influence of graded magnesium deficiencies on white blood cell counts and lymphocyte subpopulations in rats. | *16955720* 16955720 | ||
258. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. | *17402291* 17402291 | ||
PMC3087884 259. High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. | *19204407* 19204407 | ||
260. Intra-articular magnesium sulfate (MgSO4) reduces experimental osteoarthritis and nociception: association with attenuation of N-methyl-D-aspartate (NMDA) receptor subunit 1 phosphorylation and apoptosis in rat chondrocytes. | *19490963* 19490963 | ||
PMC2590924 261. Structural and biochemical studies of TREX1 inhibition by metals. Identification of a new active histidine conserved in DEDDh exonucleases. | *18780819* 18780819 | ||
262. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. | *18396393* 18396393 | ||
PMC2643349 263. Polyethylene glycol, unique among laxatives, suppresses aberrant crypt foci, by elimination of cells. | *16716974* 16716974 | ||
PMC2749010 264. Emergency presentation and management of acute severe asthma in children. Scand J Trauma Resusc Emerg Med 2009; 17 (ä): 40 | *19732437* 19732437 | ||
PMC2735421 265. Differential binding of inorganic particles to MARCO. | *18836211* 18836211 | ||
PMC1070764 266. Magnesium sulfate is effective for severe acute asthma treated in the emergency department. | *18751237* 18751237 | ||
267. Cell membranes in cytotoxicity. | *197829* 197829 | ||
268. Magnesium's role in pediatric asthma. | *17765823* 17765823 | ||
269. An under-recognized complication of treatment of acute severe asthma. | *18410827* 18410827 | ||
270. Serum magnesium levels in asthmatic patients during acute exacerbations of asthma. | *1736905* 1736905 | ||
271. Unlabeled uses of nebulized medications. | *16960254* 16960254 | ||
272. The syndrome of alcoholic ketoacidosis. | *1867237* 1867237 | ||
273. Cisplatin nephrotoxicity: a review. | *17700201* 17700201 | ||
274. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. | *16645424* 16645424 | ||
275. Management of status asthmaticus. | *1957999* 1957999 | ||
276. Magnesium sulfate-induced nonallergic anaphylaxis. | *17378266* 17378266 | ||
277. Intravenous magnesium sulfate in acute, life-threatening asthma. | *1952314* 1952314 | ||
278. Magnesium and the inflammatory response: potential physiopathological implications. | *16712775* 16712775 | ||
279. Paediatric acute asthma management in Australia and New Zealand: practice patterns in the context of clinical practice guidelines. | *18356383* 18356383 | ||
280. Inorganic cytoplasmic inclusions in alveolar macrophages. The role of cigarette smoking. | *203246* 203246 | ||
281. Effects of supplementation with higher levels of manganese and magnesium on immune function. | *17679553* 17679553 | ||
282. Synergistic effect of magnesium and calcium ions in the activation of phospholipase A2 of liver macrophages. | *2018502* 2018502 | ||
283. Effect of Zn and Mg in tricalcium phosphate and in culture medium on apoptosis and actin ring formation of mature osteoclasts. | *18824780* 18824780 | ||
284. Neuroprotective gene profile in the brain of magnesium-deficient mice. | *18400454* 18400454 | ||
285. Magnesium tanshinoate B protects endothelial cells against oxidized lipoprotein-induced apoptosis. | *18066107* 18066107 | ||
286. Magnesium and tumors: ally or foe? | *19203841* 19203841 | ||
287. Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction. | *20299332* 20299332 | ||
288. Lysis of virus-infected target cells by antibody-dependent cellular cytotoxicity. I. General requirements of the reaction and temporal relationship between lethal hits and cytolysis. | *193647* 193647 | ||
289. Bronchodilating effect of intravenous magnesium sulfate. | *1989832* 1989832 | ||
290. [Prevention of osteoporosis by foods and dietary supplements. Magnesium and bone metabolism]. | *17012818* 17012818 | ||
291. Observations on serum iron, zinc, copper and magnesium in intravenously fed patients with chronic sepsis. | *16831761* 16831761 | ||
292. Alterations in trace element and plasma amino-acid profile in experimental gram-negative septicaemia. | *16831722* 16831722 | ||
293. Cell (patho)physiology of magnesium. | *18047467* 18047467 | ||
294. Magnesium sulfate for persistent pulmonary hypertension of the newborn. | *17636807* 17636807 | ||
295. COPD: magnesium in the plasma and polymorphonuclear cells of patients during a stable phase. | *17364676* 17364676 | ||
296. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. | *19885998* 19885998 | ||
297. Near-fatal pediatric asthma managed with pumpless arteriovenous carbon dioxide removal. | *17901835* 17901835 | ||
298. Magnesium-adenosine triphosphate in the treatment of shock, ischemia, and sepsis. | *1737460* 1737460 | ||
299. Managing outpatient asthma exacerbations. | *20425515* 20425515 | ||
300. Magnesium in the treatment of asthma. | *17218820* 17218820 | ||
301. Status asthmaticus in children. | *17505187* 17505187 | ||
302. The role of magnesium sulfate in the acute and chronic management of asthma. | *18043278* 18043278 | ||
303. Modulation of rat intestinal nuclear factor NF-kappaB by gum arabic. | *17486449* 17486449 | ||
304. Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha. | *1935494* 1935494 | ||
305. Acute severe asthma: new approaches to assessment and treatment. | *19911854* 19911854 | ||
306. Review article: management of acute severe and near-fatal asthma. | *19682010* 19682010 | ||
307. Culture and functional studies of mouse macrophages on native-like fibrillar type I collagen. | *19124174* 19124174 | ||
308. Efficacy of magnesium in children with bronchial asthma. | *17987053* 17987053 | ||
309. Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial. | *16788707* 16788707 | ||
310. Aminophylline for treating asthma and chronic obstructive pulmonary disease. | *20477194* 20477194 | ||
311. TNFalpha receptor knockout in mice reduces adverse effects of magnesium deficiency on bone. | *19919525* 19919525 | ||
312. Vitamin K2, a gamma-carboxylating factor of gla-proteins, normalizes the bone crystal nucleation impaired by Mg-insufficiency. | *18785118* 18785118 | ||
313. Early events of the immune response mediated by leukocyte integrins. | *1695194* 1695194 | ||
314. Effects of magnesium supplementation on the glutathione redox system in atopic asthmatic children. | *18516713* 18516713 | ||
315. Dietary calcium supplementation suppresses bone formation in magnesium-deficient rats. | *17048189* 17048189 | ||
316. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009; 28 (2): 131-41 | *19828898* 19828898 | ||
317. N-acetylcysteine partially reverses oxidative stress and apoptosis exacerbated by Mg-deficiency culturing conditions in primary cultures of rat and human hepatocytes. | *17031004* 17031004 | ||
318. Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial. | *20100026* 20100026 | ||
319. Treatment of status asthmaticus with intravenous magnesium sulfate. | *2010425* 2010425 | ||
320. Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor". | *1660481* 1660481 | ||
321. Superoxide radicals scavenging and xanthine oxidase inhibitory activity of magnesium lithospermate B from Salvia miltiorrhiza. | *18686136* 18686136 | ||
322. Macrophage activation for intracellular killing as induced by calcium ionophore. Correlation with biologic and biochemical events. | *1898600* 1898600 | ||
323. Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. | *19540598* 19540598 | ||
324. Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway. | *16952401* 16952401 | ||
325. Mechanisms of action of neuroprotectants in stroke. | *17895214* 17895214 | ||
326. Intravenous magnesium sulphate vs. inhaled nitric oxide for moderate, persistent pulmonary hypertension of the newborn. A Multicentre, retrospective study. | *18048460* 18048460 | ||
327. Intravenous magnesium sulfate in acute asthma. | *1967183* 1967183 | ||
328. Measurement of ionized magnesium in whole blood, plasma and serum with a new ion-selective electrode in healthy and diseased human subjects. | *1844565* 1844565 | ||
329. Relation of magnesium to osteoporosis and calcium urolithiasis. | *1844560* 1844560 | ||
330. The role of magnesium in lung diseases: asthma, allergy and pulmonary hypertension. | *1844555* 1844555 | ||
331. Cardiovascular risk factors and magnesium: relationships to atherosclerosis, ischemic heart disease and hypertension. | *1844551* 1844551 | ||
332. Hypothesis for risk of death or serious sequela from asthmatic use of magnesium throat lozenges due to 8- to 310-fold rhinovirus release increase by concentrated magnesium. | *19713049* 19713049 | ||
333. Impaired calcium uptake by cardiac sarcoplasmic reticulum and its underlying mechanism in endotoxin shock. | *1770948* 1770948 | ||
334. What is their fate after magnesium sulfate? | *20234146* 20234146 | ||
335. Magnesium transport in hypertension. | *18029156* 18029156 | ||
336. Association of nutrient intake and wheeze or asthma in a Greek pre-school population. | *19744220* 19744220 | ||
337. Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro. | *19752584* 19752584 | ||
338. Changes of magnesium serum levels in patients with acute ischemic stroke and acute infections. | *20067167* 20067167 | ||
339. Hungriger Knochen nach Parathyreoidektomie--Das "Hungry Bone Syndrome". | *17685087* 17685087 | ||
340. Effects of a deficient magnesium supply during the dry period on bone turnover of dairy cows at parturition. | *1776234* 1776234 | ||
341. North American practice patterns of intravenous magnesium therapy in severe acute asthma in children. | *21175517* 21175517 | ||
342. Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: cross-talk among cytokines, Mg2+, NF-kappaB, and de novo ceramide. | *21984552* 21984552 | ||
PMC3264499 343. Disturbances of the hypothalamic-pituitary-adrenal axis and plasma electrolytes during experimental sepsis. | *22208725* 22208725 | ||
344. Effectiveness of magnesium sulfate as initial treatment of acute severe asthma in children, conducted in a tertiary-level university hospital: a randomized, controlled trial. | *22859321* 22859321 | ||
PMC3269605 345. Magnesium sulfate for acute asthma in adults: a systematic literature review. | *22348210* 22348210 | ||
PMC3511825 346. A key role for Mg(2+) in TRPM7's control of ROS levels during cell stress. | *22587440* 22587440 | ||
347. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. | *20600865* 20600865 | ||
PMC3214234 348. Fibroblast response to lanthanoid metal ion stimulation: potential contribution to fibrotic tissue injury. | *21484406* 21484406 | ||
PMC3111424 349. Comparison of morphological changes in efferent lymph nodes after implantation of resorbable and non-resorbable implants in rabbits. | *21521497* 21521497 | ||
PMC3207172 350. Characterization of Mg2+ inhibition of mitochondrial Ca2+ uptake by a mechanistic model of mitochondrial Ca2+ uniporter. | *22067144* 22067144 | ||
PMC3134422 351. Microcirculatory changes during open label magnesium sulphate infusion in patients with severe sepsis and septic shock. | *21672227* 21672227 | ||
352. Intravenous magnesium sulphate prevents intravenous salbutamol tachycardia in asthma. | *21081685* 21081685 | ||
PMC3307379 353. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats. | *22287575* 22287575 | ||
PMC3032522 354. Magnesium induces neuronal apoptosis by suppressing excitability. | *21364668* 21364668 | ||
355. Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. Circ J 2011; 75 (2): 237-45 | *21150127* 21150127 | ||
PMC3370314 356. The effect of acute magnesium loading on the maximal exercise performance of stable chronic obstructive pulmonary disease patients. | *22760901* 22760901 | ||
PMC3532932 357. Management of mineral and bone disorder after kidney transplantation. | *22614626* 22614626 | ||
PMC3556002 358. The efficacy of magnesium sulfate loading on microalbuminuria following SIRS: One step forward in dosing. | *23351890* 23351890 | ||
PMC3609575 359. Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. | *23250359* 23250359 | ||
PMC3043756 360. Fluid and electrolyte disturbances in critically ill patients. | *21468200* 21468200 | ||
361. Therapeutic effect of magnesium sulphate on carbon monoxide toxicity-mediated brain lipid peroxidation. | *23436663* 23436663 | ||
PMC3095368 362. Magnesium Lithospermate B Protects Cardiomyocytes from Ischemic Injury Via Inhibition of TAB1-p38 Apoptosis Signaling. | *21607062* 21607062 | ||
PMC1457488 363. Studies on the mechanism of macrophage aggregation induced by lymphokines. | *223977* 223977 | ||
364. Vitamin D deficiency as a strong predictor of asthma in children. | *21986034* 21986034 | ||
PMC3227031 365. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? | *22140321* 22140321 | ||
PMC3533145 366. Magnesium concentration in acute asthmatic children. | *23429727* 23429727 | ||
PMC3168515 367. Diagnosis and therapy of microscopic colitis with presence of foamy macrophages in children. | *21991528* 21991528 | ||
PMC2958049 368. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids. | *20626112* 20626112 | ||
PMC3884513 369. Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. | *22611240* 22611240 | ||
PMC3218197 370. Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-alpha. | *21932365* 21932365 | ||
371. Magnesium, a drug of diverse use. | *22355971* 22355971 | ||
PMC3470434 372. Feasibility of short-term infusion of magnesium sulfate in pediatric patients with status asthmaticus. | *23118666* 23118666 | ||
PMC3469115 373. Magnesium sulfate for severe acute asthma in children. | *23300395* 23300395 | ||
374. Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro. | *23596818* 23596818 | ||
PMC3195797 375. Idiopathic severe hypermagnesemia in an extremely low birth weight infant on the first day of life. | *22025925* 22025925 | ||
376. Extracellular magnesium and in vitro cell differentiation: different behaviour of different cells. | *23614966* 23614966 | ||
377. Blocking the rise of intracellular calcium inhibits the growth of cells cultured in different concentrations of magnesium. | *22456185* 22456185 | ||
378. Magnesium supplement promotes sciatic nerve regeneration and down-regulates inflammatory response. | *21609904* 21609904 | ||
379. Magnesium deficiency and metabolic syndrome: stress and inflammation may reflect calcium activation. | *20513641* 20513641 | ||
380. Vascular biology of magnesium and its transporters in hypertension. | *21199786* 21199786 | ||
PMC3489514 381. Propofol and magnesium attenuate isoflurane-induced caspase-3 activation via inhibiting mitochondrial permeability transition pore. | *22901676* 22901676 | ||
PMC3275783 382. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. | *21750166* 21750166 | ||
PMC3298633 383. Critical care for pediatric asthma: wide care variability and challenges for study. | *22067984* 22067984 | ||
PMC53579 384. Magnesium dietary intake modulates blood lipid levels and atherogenesis. | *2308944* 2308944 | ||
PMC3568428 385. P2X7 receptor activation induces reactive oxygen species formation in erythroid cells. | *23014887* 23014887 | ||
PMC3141423 386. Elemental analysis of lung tissue particles and intracellular iron content of alveolar macrophages in pulmonary alveolar proteinosis. | *21718529* 21718529 | ||
PMC4507414 387. Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. | *21900205* 21900205 | ||
388. Combined treatment with progesterone and magnesium sulfate positively affects traumatic brain injury in immature rats. | *23546895* 23546895 | ||
389. Management of acute asthma. | *20568552* 20568552 | ||
390. The regulation of macrophage activities: role of the energy-dependent intracellular Ca2+ buffering systems. | *232819* 232819 | ||
391. Magnesium sulfate ameliorates maternal and fetal inflammation in a rat model of maternal infection. | *21272846* 21272846 | ||
392. Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates. | *23590581* 23590581 | ||
393. Granulocyte-macrophage colony-stimulating factor (GM-CSF), hypocalcemia, and hypomagnesemia. | *2185678* 2185678 | ||
394. Mechanisms of Mg2+ inhibition of BzATP-dependent Ca2+ responses in THP-1 monocytes. | *22297175* 22297175 | ||
395. Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion. | *21111716* 21111716 | ||
396. Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels. | *21040713* 21040713 | ||
397. Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats. | *20811796* 20811796 | ||
398. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss. | *2224590* 2224590 | ||
399. Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice. | *23125223* 23125223 | ||
400. Role of ERK signaling in the neuroprotective efficacy of magnesium sulfate treatment during focal cerebral ischemia in the gerbil cortex. | *21793341* 21793341 | ||
401. Role of PI3K/Akt signaling in the protective effect of magnesium sulfate against ischemia-perfusion injury of small intestine in rats. | *20819605* 20819605 | ||
402. [Magnesium disorder in metabolic bone diseases]. | *22846362* 22846362 | ||
403. The patient with asthma in the emergency department. | *21597902* 21597902 | ||
404. Magnesium and its transporters in cancer: a novel paradigm in tumour development. | *22671428* 22671428 | ||
405. Endothelial cells and magnesium: implications in atherosclerosis. | *22248353* 22248353 | ||
406. Using small molecule GSK3beta inhibitors to treat inflammation. | *20858169* 20858169 | ||
407. Management of severe acute asthma in the emergency department. | *21716106* 21716106 | ||
408. Asthma diagnosis and management. | *22487105* 22487105 | ||
409. Pro-inflammatory effects and oxidative stress in lung macrophages and epithelial cells induced by ambient particulate matter. | *23462618* 23462618 | ||
410. Protective effects of magnesium supplementation on metabolic energy derangements in lipopolysaccharide-induced cardiotoxicity in mice. | *22939974* 22939974 | ||
411. Decreased renal mRNA expression of TRPM6 is associated with hypomagnesemia in C57BL/6 asthmatic mice. | *21284342* 21284342 | ||
412. Magnesium chenoursodeoxycholic acid ameliorates carbon tetrachloride-induced liver fibrosis in rats. | *22185916* 22185916 | ||
413. Ionophore A23187 raises cyclic AMP levels in macrophages by stimulating prostaglandin E formation. | *215425* 215425 | ||
414. Effect of dolomite on the repair of bone defects in rats: histological study. | *20886435* 20886435 | ||
415. Modulation of lung-associated natural killer activity by resident and activated alveolar macrophages. | *2338360* 2338360 | ||
416. Acute bronchial asthma. | *21769523* 21769523 | ||
417. Management of status asthmaticus in children. | *20824393* 20824393 | ||
418. Chlorophyll revisited: anti-inflammatory activities of chlorophyll a and inhibition of expression of TNF-alpha gene by the same. | *22038065* 22038065 | ||
419. Magnesium lithospermate B mediates anti-inflammation targeting activator protein-1 and nuclear factor-kappa B signaling pathways in human peripheral T lymphocytes. | *22569344* 22569344 | ||
420. High-dose magnesium sulfate infusion protocol for status asthmaticus: a safety and pharmacokinetics cohort study. | *23129148* 23129148 | ||
421. Hypomagnesemia in critically ill medical patients. | *21751660* 21751660 | ||
422. Demographics, clinical course, and outcomes of children with status asthmaticus treated in a pediatric intensive care unit: 8-year review. | *23379585* 23379585 | ||
423. Magnesium affects the cytokine secretion of CD4(+) T lymphocytes in acute asthma. | *23134345* 23134345 | ||
424. Calcium and magnesium in exhaled breath condensate of children with endogenous and exogenous airway acidification. | *21815882* 21815882 | ||
425. Degradable magnesium-based implant materials with anti-inflammatory activity. | *23203562* 23203562 | ||
426. Fusion of mouse alveolar macrophages induced by 1 alpha,25-dihydroxyvitamin D3 involves extracellular, but not intracellular, calcium. | *2105966* 2105966 | ||
427. Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia. | *21602712* 21602712 | ||
428. Macrophage migration inhibition factor: interactions with calcium, magnesium, and cyclic AMP. | *212481* 212481 | ||
429. Diversity of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRL/MpJ-lpr mice. | *20842640* 20842640 | ||
430. Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs. | *22714899* 22714899 | ||
431. Magnesium deficiency results in an increased formation of osteoclasts. | *23517915* 23517915 | ||
432. Anti-inflammatory and analgesic effect of plumbagin through inhibition of nuclear factor-kappaB activation. | *20858709* 20858709 | ||
433. Magnesium sulfate inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated RAW264.7 macrophages in vitro. | *22487382* 22487382 | ||
434. Magnesium deficiency promotes secretion of high-mobility group box 1 protein from lipopolysaccharide-activated macrophages in vitro. | *22608546* 22608546 | ||
435. Magnesium sulfate mitigates acute lung injury in endotoxemia rats. | *21610432* 21610432 | ||
436. Metallic elements in exhaled breath condensate and serum of patients with exacerbation of chronic obstructive pulmonary disease. | *21305131* 21305131 | ||
437. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. | *21135566* 21135566 | ||
438. Suboptimal magnesium status in the United States: are the health consequences underestimated? | *22364157* 22364157 | ||
439. Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma. | *21152880* 21152880 | ||
440. Management of status asthmaticus in children. | *23578933* 23578933 | ||
441. Serum micronutrient concentrations and childhood asthma: the PIAMA birth cohort study. | *21929603* 21929603 | ||
442. Nutritional status and complications in children with diabetic ketoacidosis. | *22610448* 22610448 | ||
443. Magnesium use in asthma pharmacotherapy: a Pediatric Emergency Research Canada study. | *22508922* 22508922 | ||
444. Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. | *22341339* 22341339 | ||
445. Activation of calcium-insensitive phospholipase A(2) (iPLA(2)) by P2X(7) receptors in murine peritoneal macrophages. | *23041292* 23041292 | ||
446. Le magnesium, applications en soins intensifs et en anesthesiologie. | *23167136* 23167136 | ||
447. Pharmacologic approaches to life-threatening asthma. | *21490118* 21490118 | ||
448. Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial. | *23299960* 23299960 | ||
449. Lithospermic acid B protects beta-cells from cytokine-induced apoptosis by alleviating apoptotic pathways and activating anti-apoptotic pathways of Nrf2-HO-1 and Sirt1. | *21295052* 21295052 | ||
450. Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: facts and artefacts. | *22198050* 22198050 | ||
451. Magnesium disorders in horses. | *21392659* 21392659 | ||
452. Management of severe asthma exacerbation in children. | *22015722* 22015722 | ||
453. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. | *20934153* 20934153 | ||
PMC4369158 454. Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes. | *25241107* 25241107 | ||
455. Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation. | *24944268* 24944268 | ||
PMC4005165 456. Magnesium for acute exacerbation of chronic obstructive pulmonary disease: A systematic review of randomised trials. | *24791169* 24791169 | ||
PMC4822408 457. Ion channels in innate and adaptive immunity. | *25861976* 25861976 | ||
458. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway. | *23906792* 23906792 | ||
PMC4578555 459. Comparison of the reaction of bone-derived cells to enhanced MgCl2-salt concentrations. | *25482335* 25482335 | ||
460. Use of magnesium in moderating tachycardia in acute severe asthma in pregnancy. | *23687321* 23687321 | ||
PMC3730411 461. Mechanisms underlying cell death in ischemia-like damage to the rat spinal cord in vitro. | *23828570* 23828570 | ||
462. Long-term effects of mustard gas on respiratory system of Iranian veterans after Iraq-Iran war: a review. | *23735551* 23735551 | ||
PMC4557387 463. Neutrophil extracellular traps can activate alternative complement pathways. | *25963026* 25963026 | ||
PMC6599853 464. Interventions for managing asthma in pregnancy. | *25331331* 25331331 | ||
PMC4301798 465. Adenosine, lidocaine and Mg2+ improves cardiac and pulmonary function, induces reversible hypotension and exerts anti-inflammatory effects in an endotoxemic porcine model. | *25497775* 25497775 | ||
466. Extracellular Mg concentration and Ca blockers modulate the initial steps of the response of Th2 lymphocytes in co-culture with macrophages and dendritic cells. | *26083578* 26083578 | ||
PMC4550379 467. Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. | *26060214* 26060214 | ||
468. Yersinia enterocolitica-mediated degradation of neutrophil extracellular traps (NETs). | *26459885* 26459885 | ||
469. Protective effects against and potential mechanisms underlying the effect of magnesium isoglycyrrhizinate in hypoxia-reoxygenation injury in rat liver cells. | *26634511* 26634511 | ||
PMC4781380 470. MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children. | *24144222* 24144222 | ||
PMC3832323 471. Magnesium deficiency upregulates sphingomyelinases in cardiovascular tissues and cells: cross-talk among proto-oncogenes, Mg(2+), NF-kappaB and ceramide and their potential relationships to resistant hypertension, atherogenesis and cardiac failure. | *24260592* 24260592 | ||
PMC4152036 472. Magnesium isoglycyrrhizinate protects hepatic L02 cells from ischemia/reperfusion induced injury. | *25197346* 25197346 | ||
PMC3650588 473. Prevention and treatment of respiratory consequences induced by sulfur mustard in Iranian casualties. | *23671768* 23671768 | ||
PMC4232789 474. Magnesium Sulfate in Exacerbations of COPD in Patients Admitted to Internal Medicine Ward. | *25587312* 25587312 | ||
PMC4625810 475. Hypomagnesemia in Critically Ill Sepsis Patients. | *26566403* 26566403 | ||
PMC4093670 476. Use of intravenous magnesium sulfate for the treatment of an acute asthma exacerbation in pediatric patients. | *25024668* 25024668 | ||
PMC3668947 477. Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit. | *23798903* 23798903 | ||
PMC3726845 478. Magnesium: a versatile drug for anesthesiologists. | *23904932* 23904932 | ||
479. Influence of extracellular magnesium on phagocytosis and free cytosolic Mg levels in differentiated U937 and MH-S cells. | *25967881* 25967881 | ||
480. TRPM7 involvement in cancer: a potential prognostic factor. | *25367030* 25367030 | ||
481. Potential interplay between NFkappaB and PPARgamma in human dermal microvascular endothelial cells cultured in low magnesium. | *25245457* 25245457 | ||
PMC4418123 482. Relationship between Intracellular Magnesium Level, Lung Function, and Level of Asthma Control in Children with Chronic Bronchial Asthma. | *25977631* 25977631 | ||
PMC4586582 483. Magnesium in Prevention and Therapy. | *26404370* 26404370 | ||
PMC4753077 484. Hyperinsulinism in a neonate. | *24605860* 24605860 | ||
485. Magnesium in depression. | *23950577* 23950577 | ||
486. Magnesium in man: implications for health and disease. | *25540137* 25540137 | ||
PMC4167554 487. A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats. | *25229549* 25229549 | ||
PMC4123883 488. Anti-wrinkle effect of magnesium lithospermate B from Salvia miltiorrhiza BUNGE: inhibition of MMPs via NF-kB signaling. | *25099178* 25099178 | ||
PMC4251077 489. Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study. | *25485151* 25485151 | ||
490. Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study. | *25892292* 25892292 | ||
PMC4101474 491. Inactivation of TRPM7 kinase activity does not impair its channel function in mice. | *25030553* 25030553 | ||
PMC3712317 492. Zn- and Mg- containing tricalcium phosphates-based adjuvants for cancer immunotherapy. | *23857555* 23857555 | ||
493. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. | *23698380* 23698380 | ||
PMC4127587 494. Domino effect of hypomagnesemia on the innate immunity of Crohn's disease patients. | *25126398* 25126398 | ||
495. Effects of extracellular magnesium on the differentiation and function of human osteoclasts. | *24531013* 24531013 | ||
496. Randomised comparison of intravenous magnesium sulphate, terbutaline and aminophylline for children with acute severe asthma. | *25164315* 25164315 | ||
497. Intravenous magnesium sulfate reduces rates of mechanical ventilation in pediatric asthma. | *24487258* 24487258 | ||
498. Impairment of reticuloendothelial system function with sepsis and its improvement with ATP-MgCl2 plus glucose administration. | *262800* 262800 | ||
499. Antigen-independent binding of T-cells by dendritic cells and alveolar macrophages in the rat. | *2492172* 2492172 | ||
500. Pharmacologic modulation of spontaneous histamine release. | *2472760* 2472760 | ||
501. The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-kappaB and NFATc1 signaling. | *24816285* 24816285 | ||
502. Activation of NF-kappaB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKbeta expression. | *23784082* 23784082 | ||
503. Magnesium lithospermate B reduces inflammatory response in a mouse model of hepatic ischemia-reperfusion injury. | *24385154* 24385154 | ||
504. Divalent metal requirement for soluble immune response suppressor (SIRS) activity. | *2521303* 2521303 | ||
505. Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthma. | *23949578* 23949578 | ||
506. Attenuation of Magnesium Sulfate on CoCl(2)-Induced Cell Death by Activating ERK1/2/MAPK and Inhibiting HIF-1alpha via Mitochondrial Apoptotic Signaling Suppression in a Neuronal Cell Line. | *26211648* 26211648 | ||
507. Hypophosphatemia as a prognostic value in acute exacerbation of COPD. | *23659185* 23659185 | ||
508. Evaluation and treatment of critical asthma syndrome in children. | *24488329* 24488329 | ||
509. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. | *24865567* 24865567 | ||
510. Anti-inflammatory, anti-bacterial, and cytotoxic activity of fibrous clays. | *25819359* 25819359 | ||
511. Mg2+ homeostasis: the balancing act of TRPM6. | *24906182* 24906182 | ||
512. [Influence of magnesium deficiency correction on the effectiveness of bronchial asthma pharmacotherapy in children]. | *25335387* 25335387 | ||
513. Prediction of unsuccessful treatment in patients with severe acute asthma. | *23988398* 23988398 | ||
514. Management of acute asthma in the emergency department. | *24040898* 24040898 | ||
515. Deep sea minerals prolong life span of streptozotocin-induced diabetic rats by compensatory augmentation of the IGF-I-survival signaling and inhibition of apoptosis. | *25727812* 25727812 | ||
516. Magnesium lithospermate B acts against dextran sodiumsulfate-induced ulcerative colitis by inhibiting activation of the NRLP3/ASC/Caspase-1 pathway. | *26650800* 26650800 | ||
517. The efficacy of nebulized salbutamol, magnesium sulfate, and salbutamol/magnesium sulfate combination in moderate bronchiolitis. | *24687251* 24687251 | ||
518. Beneficial effect of magnesium lithospermate B on cerebral ischemia-reperfusion injury in rats involves the regulation of miR-107/glutamate transporter 1 pathway. | *26420356* 26420356 | ||
519. Effects of magnesium deficiency--more than skin deep. | *24928863* 24928863 | ||
520. Cytotoxicity and carcinogenicity of chrysotile fibres from asbestos-cement products. | *2545608* 2545608 | ||
521. Nebulized Magnesium Sulfate in Acute Bronchiolitis: A Randomized Controlled Trial. | *25731897* 25731897 | ||
522. Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway. | *25691139* 25691139 | ||
523. Effects of P-MAPA immunomodulator on Toll-like receptor 2, ROS, nitric oxide, MAPKp38 and IKK in PBMC and macrophages from dogs with visceral leishmaniasis. | *24374021* 24374021 | ||
524. Economic evaluation of nebulized magnesium sulphate in acute severe asthma in children. | *25394502* 25394502 | ||
525. Spontaneous histamine release and histamine content in normal subjects and subjects with asthma. | *2468701* 2468701 | ||
526. Relevance of chest radiography in pediatric inpatients with asthma. | *24673123* 24673123 | ||
527. Monitoring the ionic content of exhaled breath condensate in various respiratory diseases by capillary electrophoresis with contactless conductivity detection. | *25944821* 25944821 | ||
528. Severe enterovirus 68 respiratory illness in children requiring intensive care management. | *26305825* 26305825 | ||
529. Comparative effectiveness of intravenous and inhaled magnesium in acute asthma. | *24236741* 24236741 | ||
530. Do porins inhibit the macrophage phagocyting activity by stimulating the adenylate cyclase? J Cyclic Nucleotide Protein Phosphor Res 1986; 11 (2): 87-97 | *2426319* 2426319 | ||
531. The natural therapeutic magnesium lithospermate B potently provides neuroprotective effects on cerebral ischemia/reperfusion injury in rats. | *25560670* 25560670 | ||
532. Mycelia glycoproteins from Cordyceps sobolifera ameliorate cyclosporine-induced renal tubule dysfunction in rats. | *24631962* 24631962 | ||
533. Magnesium lithospermate B improves myocardial function and prevents simulated ischemia/reperfusion injury-induced H9c2 cardiomyocytes apoptosis through Akt-dependent pathway. | *24296090* 24296090 | ||
534. The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements. | *2574205* 2574205 | ||
535. Upregulation of Collagen Expression via PPARbeta/delta Activation in Aged Skin by Magnesium Lithospermate B from Salvia miltiorrhiza. | *26280594* 26280594 | ||
536. Neutrophil extracellular traps promote differentiation and function of fibroblasts. | *24740698* 24740698 | ||
537. The spectrum of onset of acute kidney injury in premature infants less than 30 weeks gestation. | *26796125* 26796125 | ||
538. Phosphoinositide 3-kinase beta, phosphoinositide 3-kinase delta, and phosphoinositide 3-kinase gamma mediate the anti-inflammatory effects of magnesium sulfate. | *25972311* 25972311 | ||
539. Magnesium sulfate provides neuroprotection in lipopolysaccharide-activated primary microglia by inhibiting NF-kappaB pathway. | *23628437* 23628437 | ||
540. Phosphoinositide 3-kinase/Akt pathway is involved in mediating the anti-inflammation effects of magnesium sulfate. | *23859135* 23859135 | ||
541. Adenosine, lidocaine, and Mg2+ (ALM): From cardiac surgery to combat casualty care--Teaching old drugs new tricks. | *26683400* 26683400 | ||
542. Correction of acute traumatic coagulopathy with small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ occurs within 5 minutes: a ROTEM analysis. | *25807406* 25807406 | ||
543. Adenosine, lidocaine and Mg2+ (ALM) induces a reversible hypotensive state, reduces lung edema and prevents coagulopathy in the rat model of polymicrobial sepsis. | *25159253* 25159253 | ||
544. Magnesium physiology and clinical therapy in veterinary critical care. | *25427407* 25427407 | ||
545. Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease. | *26061542* 26061542 | ||
546. Alterations in cellular calcium and magnesium during circulatory/septic shock. | *2682043* 2682043 | ||
547. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. | *24557875* 24557875 | ||
548. Streptococcus pyogenes CAMP factor attenuates phagocytic activity of RAW 264.7 cells. | *26482504* 26482504 | ||
549. Pigment resembling atmospheric dust in Peyer's patches. | *2548180* 2548180 | ||
550. Magnesium Lithospermate B Protects Neurons Against Amyloid beta (1-42)-Induced Neurotoxicity Through the NF-kappaB Pathway. | *26285901* 26285901 | ||
551. Nutritional evaluation in chronic obstructive pulmonary disease patients. | *24187906* 24187906 | ||
552. High-Dose Magnesium Infusions for Acute Severe Asthma in Children: If a Little Is Good, Is More Even Better? | *26841033* 26841033 | ||
553. High-Dose Magnesium Sulfate Infusion for Severe Asthma in the Emergency Department: Efficacy Study. | *26649938* 26649938 | ||
554. Management of acute asthma in the pediatric patient: an evidence-based review. | *23971269* 23971269 | ||
555. Nebulized magnesium for moderate and severe pediatric asthma: A randomized trial. | *25652104* 25652104 | ||
556. Safety and effectiveness of continuous aerosolized albuterol in the non-intensive care setting. | *25266428* 25266428 | ||
557. Antidepressant-like effects of magnesium lithospermate B in a rat model of chronic unpredictable stress. | *25857699* 25857699 | ||
558. Magnesium lithospermate B reduces myocardial ischemia/reperfusion injury in rats via regulating the inflammation response. | *23863120* 23863120 | ||
559. Pretreatment with magnesium ameliorates lipopolysaccharide-induced liver injury in mice. | *26398385* 26398385 | ||
560. The molecular biology and pathophysiology of vascular calcification. | *24685968* 24685968 | ||
561. Admission hypomagnesemia linked to septic shock in patients with systemic inflammatory response syndrome. | *26335852* 26335852 | ||
562. Intravenose Magnesium-Gabe bei Asthma bronchiale. | *2609133* 2609133 | ||
563. Which intravenous bronchodilators are being administered to children presenting with acute severe wheeze in the UK and Ireland? | *25303945* 25303945 | ||
564. Treatment of the Infected Stone. | *26475943* 26475943 | ||
565. Magnesium Lithospermate B Implicates 3'-5'-Cyclic Adenosine Monophosphate/Protein Kinase A Pathway and N-Methyl-d-Aspartate Receptors in an Experimental Traumatic Brain Injury. | *26093361* 26093361 | ||
566. Pharmacologic Management of Subarachnoid Hemorrhage. | *25701766* 25701766 | ||
567. Magnesium improves cisplatin-mediated tumor killing while protecting against cisplatin-induced nephrotoxicity. | *28424213* 28424213 | ||
PMC5796960 568. Multifaceted interventions to reduce acute exacerbations in elderly asthmatics. | *29423368* 29423368 | ||
PMC5372215 569. Near death by milk of magnesia. | *28325719* 28325719 | ||
PMC5406298 570. Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism. | *28198010* 28198010 | ||
PMC7094486 571. IV Magnesium Sulfate for Bronchiolitis: A Randomized Trial. | *28286262* 28286262 | ||
PMC5098019 572. Small-Volume Adenosine, Lidocaine, and Mg2+ 4-Hour Infusion Leads to 88% Survival after 6 Days of Experimental Sepsis in the Rat without Antibiotics. | *27581435* 27581435 | ||
PMC6599814 573. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. | *27126744* 27126744 | ||
PMC4734720 574. Amelioration of concanavalin A-induced autoimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4(+)CD25(-)CD69(+) subset proliferation. | *26869766* 26869766 | ||
575. Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial. | *29437941* 29437941 | ||
PMC5772795 576. Magnesium isoglycyrrhizinate ameliorates doxorubicin-induced acute cardiac and hepatic toxicity via anti-oxidant and anti-apoptotic mechanisms in mice. | *29399108* 29399108 | ||
PMC5143678 577. Magnesium Sulfate Prevents Placental Ischemia-Induced Increases in Brain Water Content and Cerebrospinal Fluid Cytokines in Pregnant Rats. | *28008305* 28008305 | ||
PMC5810254 578. Magnesium Lithospermate B Protects against Lipopolysaccharide-Induced Bone Loss by Inhibiting RANKL/RANK Pathway. | *29472860* 29472860 | ||
PMC5790298 579. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. | *29305409* 29305409 | ||
580. Systematic Review on Efficacy of Magnesium (Intravenous or Nebulized) for Acute Asthma Episodes in Children: Pediatric Pulmonologist's Viewpoint. | *28285285* 28285285 | ||
581. Systematic Review on Efficacy of Magnesium (Intravenous or Nebulized) for Acute Asthma Episodes in Children: Evidence-based Medicine Viewpoint. | *28285284* 28285284 | ||
PMC5296885 582. Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy. | *27584583* 27584583 | ||
PMC5669789 583. Dietary nutrients associated with preservation of lung function in Hispanic and non-Hispanic white smokers from New Mexico. | *29133979* 29133979 | ||
PMC4922805 584. Vitamin D should be supplemented more actively in elderly patients with coronary heart disease combined with COPD. | *27382272* 27382272 | ||
PMC5877525 585. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials. | *29495444* 29495444 | ||
586. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis. | *28500689* 28500689 | ||
PMC5237629 587. Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis. | *27527263* 27527263 | ||
588. A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta. | *2784432* 2784432 | ||
589. Extracellular ATP perturbs transmembrane ion fluxes, elevates cytosolic [Ca2+], and inhibits phagocytosis in mouse macrophages. | *2932438* 2932438 | ||
PMC2115096 590. Murine fetal liver macrophages bind developing erythroblasts by a divalent cation-dependent hemagglutinin. | *2831233* 2831233 | ||
PMC6144272 591. Stat3 inhibitor abrogates the expression of PD-1 ligands on lymphoma cell lines. | *28496056* 28496056 | ||
PMC5061963 592. Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes. | *27777961* 27777961 | ||
PMC5783146 593. Magnesium deficiency and increased inflammation: current perspectives. | *29403302* 29403302 | ||
594. Magnesium sulfate infusion for acute asthma in the emergency department. | *28754601* 28754601 | ||
PMC4956331 595. Comparison of Two High-Dose Magnesium Infusion Regimens in the Treatment of Status Asthmaticus. | *27453701* 27453701 | ||
596. Extracellular magnesium and calcium blockers modulate macrophage activity. | *27160489* 27160489 | ||
PMC5968247 597. The Relationship between Hypomagnesemia and Pulmonary Function Tests in Patients with Chronic Asthma. | *29455196* 29455196 | ||
PMC5709425 598. Magnesium uptake by connecting fluid-phase endocytosis to an intracellular inorganic cation filter. | *29192218* 29192218 | ||
PMC5464865 599. Magnesium isoglycyrrhizinate shows hepatoprotective effects in a cyclophosphamide-induced model of hepatic injury. | *28402274* 28402274 | ||
PMC5516748 600. The Involvement of Mg(2+) in Regulation of Cellular and Mitochondrial Functions. | *28757913* 28757913 | ||
PMC5538151 601. Anti-inflammatory Potential of Petiveria alliacea on Activated RAW264.7 Murine Macrophages. | *28808377* 28808377 | ||
PMC5690633 602. Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage. | *29145467* 29145467 | ||
PMC5080508 603. Serum Magnesium and Vitamin D Levels as Indicators of Asthma Severity. | *27818797* 27818797 | ||
PMC5772083 604. Magnesium sulfate protects the heart against carbon monoxide-induced cardiotoxicity in rats. | *29387113* 29387113 | ||
PMC5794996 605. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. | *29391410* 29391410 | ||
PMC5309879 606. In vitro and in vivo responses of macrophages to magnesium-doped titanium. | *28198427* 28198427 | ||
PMC5387745 607. A promising biodegradable magnesium alloy suitable for clinical vascular stent application. | *28397881* 28397881 | ||
PMC5637834 608. The Importance of Magnesium in Clinical Healthcare. | *29093983* 29093983 | ||
609. High-Purity Magnesium Staples Suppress Inflammatory Response in Rectal Anastomoses. | *28240546* 28240546 | ||
610. Magnesium (Mg) based interference screws developed for promoting tendon graft incorporation in bone tunnel in rabbits. | *28919510* 28919510 | ||
611. The effect of nebulised magnesium sulphate in the management of childhood moderate asthma exacerbations as adjuvant treatment. | *28153353* 28153353 | ||
612. Diagnostic value of a pattern of exhaled breath condensate biomarkers in asthmatic children. | *27592280* 27592280 | ||
613. Beneficial action of magnesium sulfate in bronchial asthma: how and why? | *27238854* 27238854 | ||
614. Maternal magnesium sulfate fetal neuroprotective effects to the fetus: inhibition of neuronal nitric oxide synthase and nuclear factor kappa-light-chain-enhancer of activated B cells activation in a rodent model. | *27018467* 27018467 | ||
615. Asthma bronchiale - Notfallmedizinische Versorgung. Anasthesiol Intensivmed Notfallmed Schmerzther 2016; 51 (6): 412-20 | *27359240* 27359240 | ||
616. Oral Application of Magnesium-L-Threonate Attenuates Vincristine-induced Allodynia and Hyperalgesia by Normalization of Tumor Necrosis Factor-alpha/Nuclear Factor-kappaB Signaling. | *28306698* 28306698 | ||
617. Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma. | *2916786* 2916786 | ||
618. Fluid and electrolyte considerations in diuretic therapy for hypertensive patients with chronic obstructive pulmonary disease. | *2867747* 2867747 | ||
619. 'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation. | *2783143* 2783143 | ||
620. Phosphatase of regenerating liver maintains cellular magnesium homeostasis. | *29487165* 29487165 | ||
621. Magnesium isoglycyrrhizinate promotes the activated hepatic stellate cells apoptosis via endoplasmic reticulum stress and ameliorates fibrogenesis in vitro and in vivo. | *29048780* 29048780 | ||
622. Improved osteogenesis and angiogenesis of magnesium-doped calcium phosphate cement via macrophage immunomodulation. | *27709132* 27709132 | ||
623. Esomeprazole ameliorates CCl4 induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers. | *29156525* 29156525 | ||
624. Magnesium Isoglycyrrhizinate attenuates lipopolysaccharide-induced depressive-like behavior in mice. | *27978497* 27978497 | ||
625. High magnesium prevents matrix vesicle-mediated mineralization in human bone marrow-derived mesenchymal stem cells via mitochondrial pathway and autophagy. | *29024399* 29024399 | ||
626. Studies on phagocytosis of unopsonized rabbit erythrocytes by human monocytes. | *2834070* 2834070 | ||
627. Mpn491, a secreted nuclease of Mycoplasma pneumoniae, plays a critical role in evading killing by neutrophil extracellular traps. | *27603754* 27603754 | ||
628. Occult gastrointestinal bleeding in high-risk intensive care unit patients receiving antacid prophylaxis: frequency and significance. | *2783669* 2783669 | ||
629. Protective Effects of Magnesium Sulfate on Radiation Induced Brain Injury in Rats. | *29366417* 29366417 | ||
630. Diagnosis and Treatment of Childhood Migraine. | *27704257* 27704257 | ||
631. Comparative study of antifibrotic activity of some magnesium-containing supplements on experimental liver toxicity. Molecular study. | *27151930* 27151930 | ||
632. Diagnosis and management of acute exacerbation of chronic obstructive pulmonary disease [digest]. | *29068643* 29068643 | ||
633. Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma. | *27909740* 27909740 | ||
634. (E)-2-Methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol attenuates PMA-induced inflammatory responses in human monocytic cells through PKCdelta/JNK/AP-1 pathways. | *29371085* 29371085 | ||
635. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-kappaB/NLRP3 inflammasome activation and lipid metabolism disorder. | *28526339* 28526339 | ||
636. Effects of nebulised magnesium sulphate on inflammation and function of the guinea-pig airway. | *28284753* 28284753 | ||
637. Vascular sphingolipids in physiological and pathological adaptation. | *27100498* 27100498 | ||
638. Review: UPDATE sul metabolismo del magnesio. | *28134397* 28134397 | ||
639. Magnesium isoglycyrrhizinate attenuates D-galactosamine/lipopolysaccharides induced acute liver injury of rat via regulation of the p38-MAPK and NF-kappaB signaling pathways. | *29486613* 29486613 | ||
640. Serum Total Magnesium Level and its Correlation with Symptom Control in Children with Mild Persistent Asthma. | *29349628* 29349628 | ||
641. Immune-inflammatory activation after a single laparotomy in a rat model: effect of adenosine, lidocaine and Mg(2+) infusion to dampen the stress response. | *28691873* 28691873 | ||
642. Effect of magnesium deficiency on interleukin production by Fisher rats: effect of interleukins on reduced in vitro lymphocyte responses to concanavalin A and lipopolysaccharide. | *2788143* 2788143 | ||
643. Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-kappaB signaling pathway in mice. | *29274625* 29274625 | ||
644. The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters. | *28218351* 28218351 | ||
645. Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms. | *27220460* 27220460 | ||
646. Pediatric acute asthma exacerbations: Evaluation and management from emergency department to intensive care unit. | *27116362* 27116362 | ||
647. Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone. | *2763874* 2763874 | ||
648. Up-Regulation of Transient Receptor Potential Melastatin 6 Channel Expression by Tumor Necrosis Factor-alpha in the Presence of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. | *27925186* 27925186 | ||
649. Magnesium: An Overlooked Electrolyte. | *28222929* 28222929 | ||
650. A stepwise approach to pediatric asthma. | *28459888* 28459888 | ||
651. Magnesium Lithospermate B Suppresses Lipopolysaccharide-Induced Neuroinflammation in BV2 Microglial Cells and Attenuates Neurodegeneration in Lipopolysaccharide-Injected Mice. | *29196883* 29196883 | ||
652. Regulatory responses of hepatocytes, macrophages and vascular endothelial cells to magnesium deficiency. | *29454997* 29454997 | ||
653. Outcomes of paediatric critical care asthma patients. | *29468765* 29468765 | ||
654. Effects of MgSO4 on inhibiting Nod-like receptor protein 3 inflammasome involve decreasing intracellular calcium. | *29229137* 29229137 | ||
655. Protective effect of magnesium acetyltaurate against NMDA-induced retinal damage involves restoration of minerals and trace elements homeostasis. | *27908408* 27908408 | ||
656. 3% NaCl adenosine, lidocaine, Mg2+ (ALM) bolus and 4 hours "drip" infusion reduces noncompressible hemorrhage by 60% in a rat model. | *28520687* 28520687 | ||
657. Evaluation of adenosine, lidocaine, and magnesium for enhancement of platelet function during storage. | *28383470* 28383470 | ||
658. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. | *2761061* 2761061 | ||
659. Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats. | *28760336* 28760336 | ||
660. Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy. | *27659510* 27659510 | ||
661. Macrophage phagocytosis of biomedical Mg alloy degradation products prepared by electrochemical method. | *28415404* 28415404 | ||
662. Magnesium to counteract elastin degradation and vascular calcification in chronic obstructive pulmonary disease. | *28915968* 28915968 | ||
663. Ernahrung und Knochengesundheit. | *27439256* 27439256 | ||
664. A case of iatrogenic acute hypermagnesemia mimicking sepsis. | *27467105* 27467105 | ||
665. Magnesium isoglycyrrhizinate protects against renalischemiareperfusion injury in a rat model via antiinflammation, antioxidation and antiapoptosis. | *28714024* 28714024 | ||
666. Ca2+/Mg2+ homeostasisrelated TRPM7 channel mediates chondrocyte hypertrophy via regulation of the PI3KAkt signaling pathway. | *28849029* 28849029 | ||
667. Two-Dimensional Magnesium Phosphate Nanosheets Form Highly Thixotropic Gels That Up-Regulate Bone Formation. | *27280476* 27280476 | ||
668. Protective effect of magnesium acetyltaurate against endothelin-induced retinal and optic nerve injury. | *27012609* 27012609 | ||
669. Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina. | *27568334* 27568334 | ||
670. Nebulised magnesium sulphate in the management of asthma. | *27821003* 27821003 | ||
671. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. | *27522304* 27522304 | ||
672. Magnesium Sulfate for Acute Asthma in Children: A Good Option, but How to Use It? | *27144704* 27144704 | ||
673. Clinical Course of Enterovirus D68 in Hospitalized Children. | *28187115* 28187115 | ||
674. Magnesium Lithospermate B from Salvia miltiorrhiza Bunge Ameliorates Aging-Induced Renal Inflammation and Senescence via NADPH Oxidase-Mediated Reactive Oxygen Generation. | *28211114* 28211114 | ||
675. The Effects of Magnesium Sulfate on the Inflammatory Response of Placentas Perfused With Lipopolysaccharide: Using the Ex Vivo Dual-Perfused Human Single-Cotyledon Model. | *29113582* 29113582 | ||
676. Magnesium and the pathogenesis of toxic shock syndrome. Rev Infect Dis 1989; 11 Suppl 1 (ä): S167-73; discussion S173-5 | *2928633* 2928633 | ||
677. Effect of trace metals on the synthesis of toxic shock syndrome toxin 1. Rev Infect Dis 1989; 11 Suppl 1 (ä): S145-49; discussion S149-50 | *2928630* 2928630 | ||
678. Does Hypomagnesemia Impact on the Outcome of Patients Admitted to the Intensive Care Unit? A Systematic Review and Meta-Analysis. | *27753792* 27753792 | ||
679. Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. | *28885495* 28885495 | ||
680. Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review | *31657888* 31657888 | ||
681. The role of magnesium in edema and blood brain barrier disruption | *29920006* 29920006 | ||
PMC6629001 682. TRPM7 channel inhibition exacerbates pulmonary arterial hypertension through MEK/ERK pathway. | *31219801* 31219801 | ||
683. Intravenous Magnesium Sulfate for Acute Asthma Exacerbations. | *30633478* 30633478 | ||
PMC6203428 684. Multimodal General Anesthesia: Theory and Practice. | *30252709* 30252709 | ||
PMC5956596 685. Pseudogout - a rare manifestation of hungry bone syndrome after focused parathyroidectomy. | *29607728* 29607728 | ||
686. Magnesium augments immunosuppressive effects of a corticosteroid in obese mice with airway inflammation. | *31175714* 31175714 | ||
687. Characteristics and outcomes of treatment in status asthmaticus patients at emergency department. | *29888929* 29888929 | ||
688. Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation. | *31421659* 31421659 | ||
689. Magnesium lithospermate B attenuates renal injury in 5/6 renal ablation/infarction rats by mitochondrial pathway of apoptosis. | *31387002* 31387002 | ||
PMC6163591 690. The Role of Calcium in Inflammation-Associated Bone Resorption. | *30071694* 30071694 | ||
PMC5878337 691. Extracorporeal membrane oxygenation (ECMO) for near-fatal asthma refractory to conventional ventilation. | *29559484* 29559484 | ||
PMC5876344 692. Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines. | *29619269* 29619269 | ||
PMC6754918 693. A Loading Dose of IV Salbutamol in an Adolescent with Severe Acute Asthma and Cardiac Arrest. | *31583152* 31583152 | ||
694. Magnesium sulfate attenuates lipopolysaccharides-induced acute lung injury in mice. | *31670284* 31670284 | ||
PMC5996226 695. Dataset on assessment of magnesium isoglycyrrhizinate injection for dairy diet and body weight in fructose-induced metabolic syndrome of rats. | *29896493* 29896493 | ||
PMC7028840 696. Current practices in children with severe acute asthma across European PICUs: an ESPNIC survey. | *31797080* 31797080 | ||
697. Magnesium sulphate in the Emergency Department: an old, new friend. | *31115035* 31115035 | ||
PMC5988891 698. Magnesium Ions Inhibit the Expression of Tumor Necrosis Factor alpha and the Activity of gamma-Secretase in a beta-Amyloid Protein-Dependent Mechanism in APP/PS1 Transgenic Mice. | *29899688* 29899688 | ||
PMC6444054 699. Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2. | *30971913* 30971913 | ||
PMC6167412 700. Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-beta-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2. | *30319402* 30319402 | ||
PMC6535436 701. Long QT and death in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease is not related to electrolyte disorders. | *31190790* 31190790 | ||
PMC5926493 702. Magnesium and Human Health: Perspectives and Research Directions. | *29849626* 29849626 | ||
PMC6770589 703. Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats. | *31540416* 31540416 | ||
PMC6358963 704. Magnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D(3). | *30658432* 30658432 | ||
PMC6055085 705. The role of PPAR-gamma and NFKB genes expression in muscle to improve hyperglycemia in STZ-induced diabetic rat following magnesium sulfate administration. | *30042813* 30042813 | ||
706. Priming of neutrophils and macrophages for enhanced release of superoxide anion by the calcium ionophore ionomycin. Implications for regulation of the respiratory burst. | *3040759* 3040759 | ||
707. Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line. | *2950094* 2950094 | ||
708. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. | *3038867* 3038867 | ||
709. Enhancement by Ca2+ or Mg2+ of catalytic activity of the superoxide-producing NADPH oxidase in membrane fractions of human neutrophils and monocytes. | *2982870* 2982870 | ||
PMC6417243 710. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. | *30866950* 30866950 | ||
PMC424494 711. Relationship of superoxide production to cytoplasmic free calcium in human monocytes. | *3007579* 3007579 | ||
PMC6637517 712. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway. | *31319868* 31319868 | ||
PMC6330805 713. Serum magnesium levels and its correlation with level of control in patients with asthma: A hospital-based, cross-sectional, prospective study. | *30604720* 30604720 | ||
PMC6120318 714. Serum magnesium levels and its correlation with level of control in patients with asthma: A hospital-based, cross-sectional, prospective study. | *30168460* 30168460 | ||
PMC6323247 715. Magnesium sulfate ameliorates carbon monoxideinduced cerebral injury in male rats. | *30569139* 30569139 | ||
PMC6066271 716. Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress. | *30090013* 30090013 | ||
PMC6225288 717. Mechanism of Action of Magnesium Lithospermate B against Aging and Obesity-Induced ER Stress, Insulin Resistance, and Inflammsome Formation in the Liver. | *30134566* 30134566 | ||
PMC6461616 718. Immunoregulation of macrophages by dynamic ligand presentation via ligand-cation coordination. | *30979900* 30979900 | ||
PMC6379356 719. The role of oral magnesium supplements for the management of stable bronchial asthma: a systematic review and meta-analysis. | *30778086* 30778086 | ||
PMC6266218 720. Additional Vitamin and Mineral Support for Patients with Severe Burns: A Nationwide Experience from a Catastrophic Color-Dust Explosion Event in Taiwan. | *30453517* 30453517 | ||
PMC6304849 721. Protective Effects of Different Kinds of Filtered Water on Hypertensive Mouse by Suppressing Oxidative Stress and Inflammation. | *30622665* 30622665 | ||
PMC7035964 722. Magnesium sulfate inhibits inflammation through P2X7 receptors in human umbilical vein endothelial cells. | *31493768* 31493768 | ||
723. Medication Regimens for Managing Acute Asthma. | *29794211* 29794211 | ||
PMC6378568 724. Three cases of transient neonatal pseudohypoparathyroidism. | *30799898* 30799898 | ||
725. Hypomagnesemia and hypermagnesemia. | *30220246* 30220246 | ||
PMC6786373 726. Magnesium lithospermate B protects the endothelium from inflammation-induced dysfunction through activation of Nrf2 pathway. | *30617294* 30617294 | ||
727. Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study. | *30595390* 30595390 | ||
728. Red Ginseng Reduces Inflammatory Response via Suppression MAPK/P38 Signaling and p65 Nuclear Proteins Translocation in Rats and Raw 264.7 Macrophage. | *31645122* 31645122 | ||
729. Neuroprotective Effects of Magnesium Lithospermate B against Subarachnoid Hemorrhage in Rats. | *30149758* 30149758 | ||
730. Calcium oxalate in sarcoid granulomas. With particular reference to the small ovoid body and a note on the finding of dolomite. | *3177273* 3177273 | ||
731. Fatal Hypermagnesemia Due to Laxative Use. | *29661354* 29661354 | ||
732. PI3K Catalytic Subunits alpha and beta Modulate Cell Death and IL-6 Secretion Induced by Talc Particles in Human Lung Carcinoma Cells. | *31513749* 31513749 | ||
733. An In Situ Depot for Continuous Evolution of Gaseous H2 Mediated by a Magnesium Passivation/Activation Cycle for Treating Osteoarthritis. | *29923670* 29923670 | ||
734. Pretreatment of simvastatin on liver trace element levels during endotoxemia. | *30450988* 30450988 | ||
735. Protein phosphatase magnesium-dependent 1A induces inflammation in rheumatoid arthritis. | *31791585* 31791585 | ||
736. Activation of Dusp14 protects against osteoclast generation and bone loss by regulating AMPKalpha-dependent manner. | *31526569* 31526569 | ||
737. NIPA2 regulates osteoblast function via its effect on apoptosis pathways in type 2 diabetes osteoporosis. | *31003774* 31003774 | ||
738. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1. | *31085161* 31085161 | ||
739. The Impact of Trace Minerals on Bone Metabolism. | *30467628* 30467628 | ||
740. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation. | *29957470* 29957470 | ||
741. Magnesium isoglycyrrhizinate suppresses LPS-induced inflammation and oxidative stress through inhibiting NF-kappaB and MAPK pathways in RAW264.7 cells. | *30617018* 30617018 | ||
742. Bone metabolism in pediatric burned patients: A review. | *30077487* 30077487 | ||
743. Inflammation-mediated osteopenia (IMO) during acute inflammation in rats is due to a transient inhibition of bone formation. | *3124941* 3124941 | ||
744. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis. | *31250885* 31250885 | ||
745. Magnesium protects against sepsis by blocking gasdermin D N-terminal-induced pyroptosis. | *31209359* 31209359 | ||
746. Reduced inflammatory response by incorporating magnesium into porous TiO2 coating on titanium substrate. | *30041151* 30041151 | ||
747. Magnesium lithospermate B inhibits titanium particles-induced osteoclast formation by c-fos and inhibiting NFATc1 expression. | *30909748* 30909748 | ||
748. NLRP3 Inflammasome Activation Leads to Epileptic Neuronal Apoptosis. | *30468127* 30468127 | ||
749. Systemic drugs with impact on osteoarthritis. | *31726891* 31726891 | ||
750. Deep sea minerals ameliorate diabetic-induced inflammation via inhibition of TNFalpha signaling pathways. | *31794124* 31794124 | ||
751. Effect of magnesium supplementation on lactate clearance in critically ill patients with severe sepsis: a randomized clinical trial. | *31814044* 31814044 | ||
752. Prospective study of serum and ionized magnesium pharmacokinetics in the treatment of children with severe acute asthma. | *30259065* 30259065 | ||
753. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. | *30501441* 30501441 | ||
754. LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytes. | *3100481* 3100481 | ||
755. The role of magnesium in different inflammatory diseases. | *31172335* 31172335 | ||
756. Magnesium sulfate inhibits binding of lipopolysaccharide to THP-1 cells by reducing expression of cluster of differentiation 14. | *30721372* 30721372 | ||
757. Ameliorative effect of Magnesium Isoglycyrrhizinate on hepatic encephalopathy by Epirubicin. | *31351363* 31351363 | ||
758. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. | *31264087* 31264087 | ||
759. Deep ocean minerals inhibit IL-6 and IGFIIR hypertrophic signaling pathways to attenuate diabetes-induced hypertrophy in rat hearts. | *31095463* 31095463 | ||
760. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. | *31411907* 31411907 | ||
761. Effect of parenteral magnesium on pulmonary function, plasma cAMP, and histamine in bronchial asthma. | *2991184* 2991184 | ||
762. Possible therapeutic effect of magnesium in ocular diseases. | *31730524* 31730524 | ||
763. Magnesium alginate in children with uncontrolled asthma. | *30945510* 30945510 | ||
764. Magnesium protects mouse hippocampal HT22 cells against hypoxia-induced injury by upregulation of miR-221. | *31512791* 31512791 | ||
765. High concentration magnesium inhibits extracellular matrix calcification and protects articular cartilage via Erk/autophagy pathway. | *31161622* 31161622 | ||
766. Deactivation of the respiratory burst in activated macrophages: evidence for alteration of signal transduction. | *3005415* 3005415 | ||
767. B lymphocyte expression of a recognition locus for human monocytes and macrophages. | *309902* 309902 | ||
768. Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management. | *29914278* 29914278 | ||
769. Fetal neuroprotective mechanism of maternal magnesium sulfate for late gestation inflammation: in a rodent model. | *30835601* 30835601 | ||
770. Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorption. | *31825817* 31825817 | ||
771. An insight into the role of magnesium in the immunomodulatory properties of mesenchymal stem cells. | *29554498* 29554498 | ||
772. Comparison of the Severity of Respiratory Disease in Children Testing Positive for Enterovirus D68 and Human Rhinovirus. | *29655864* 29655864 | ||
773. Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock: A model for studying differential gene expression and extending biological time. | *31162330* 31162330 | ||
774. Adenosine, lidocaine, and Mg2+ (ALM) resuscitation fluid protects against experimental traumatic brain injury. | *29554045* 29554045 | ||
775. Protective effects of magnesium sulfate against doxorubicin induced cardiotoxicity in rats. | *29940240* 29940240 | ||
776. Magnesium deficiency heightens lipopolysaccharide-induced inflammation and enhances monocyte adhesion in human umbilical vein endothelial cells. | *30398154* 30398154 | ||
777. Varying magnesium concentration elicits changes in inflammatory response in human umbilical vein endothelial cells (HUVECs). | *30530425* 30530425 | ||
778. Magnesium, Staphylococcus aureus and toxic shock syndrome. | *3075248* 3075248 | ||
779. Magnesium and immune function: an overview. | *3075245* 3075245 | ||
780. Phagocytes and monokines: perspectives on metabolic regulation in sepsis. | *3075244* 3075244 | ||
781. Magnesium and the lungs. | *3072451* 3072451 | ||
782. Down-Regulated Expression of Magnesium Transporter Genes Following a High Magnesium Diet Attenuates Sciatic Nerve Crush Injury. | *29672725* 29672725 | ||
783. Magnesium isoglycyrrhizinate alleviates liver injury in obese rats with acute necrotizing pancreatitis. | *30396756* 30396756 | ||
PMC6693989 784. A Statewide Study of the Epidemiology of Emergency Medical Services' Management of Pediatric Asthma. | *30829849* 30829849 | ||
785. Epidemiology, Comorbidities, and Outcomes of Posterior Reversible Encephalopathy Syndrome in Children in the United States. | *31481327* 31481327 | ||
786. Safety of prolonged magnesium sulfate infusions during treatment for severe pediatric status asthmaticus. | *31478612* 31478612 | ||
787. The effectiveness of magnesium sulfate for status asthmaticus outside the intensive care setting. | *29660840* 29660840 | ||
788. Deregulated renal magnesium transport during lipopolysaccharide-induced acute kidney injury in mice. | *30726531* 30726531 | ||
789. Inhaled calcium salts inhibit tobacco smoke-induced inflammation by modulating expression of chemokines and cytokines. | *30359782* 30359782 | ||
790. Association between trace elements levels and asthma susceptibility. | *30509699* 30509699 | ||
791. Role of magnesium ion in the pathogenesis of toxic shock syndrome. | *3137706* 3137706 | ||
792. [Magnesium and vitamin B2 status of children with bronchial asthma and obesity]. | *31265778* 31265778 | ||
PMC2019962 793. Hepatic coma with renal failure, treated by repeated exchange transfusion. | *5652715* 5652715 | ||
PMC6885163 794. Magnesium Enhances Osteogenesis of BMSCs by Tuning Osteoimmunomodulation. | *31828131* 31828131 | ||
PMC1667821 795. Effect of divalent cations on lysosomal enzyme release from macrophages [proceedings]. | *338078* 338078 | ||
PMC1536980 796. Mechanisms of macrophage activation. | *6254703* 6254703 | ||
797. The role of Mg2+ and Ca2+ in the direct macrophage-mediated tumor cell lysis. | *6797841* 6797841 | ||
798. The role of divalent cations in antibody-dependent macrophage-mediated tumor lysis. | *6771163* 6771163 | ||
PMC6902094 799. A Biodegradable Mg-Based Alloy Inhibited the Inflammatory Response of THP-1 Cell-Derived Macrophages Through the TRPM7-PI3K-AKT1 Signaling Axis. | *31849975* 31849975 | ||
PMC1409552 800. The adherence of leucocytes and platelets induced by fixed IgG antibody or complement. | *4977002* 4977002 | ||
PMC6981685 801. The Use of Proton Pump Inhibitors May Increase Symptoms of Muscle Function Loss in Patients with Chronic Illnesses. | *31947724* 31947724 | ||
802. Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. | *3392016* 3392016 | ||
PMC2111555 803. Interaction of chemotactic factors with human macrophages. Induction of transmembrane potential changes. | *410816* 410816 | ||
PMC2109045 804. Quantitative studies of phagocytosis. Kinetic effects of cations and heat-labile opsonin. | *4738105* 4738105 | ||
805. Regulation of macrophage lysosomal enzyme secretion: role of arachidonate metabolites, divalent cations and cyclic AMP. | *6255000* 6255000 | ||
806. Limpet haemocytes. II. The role of spikes in locomotion and spreading. | *4822876* 4822876 | ||
PMC301533 807. Increased adenosine triphosphatase in leukocytes of asthmatic children. | *4276134* 4276134 | ||
PMC301561 808. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. | *4847248* 4847248 | ||
PMC2138705 809. The chemical nature of macrophage RNA-antigen complexes and their relevance to immune induction. | *5807279* 5807279 | ||
PMC354784 810. Intracellular restriction on the growth of induced subgroup E avian type C viruses in chicken cells. | *58079* 58079 | ||
811. EFFICACY OF MAGNESIUM SULPHATE TREATMENT IN CHILDREN WITH ACUTE ASTHMA. | *32069472* 32069472 | ||
PMC323503 812. Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. | *3458184* 3458184 | ||
PMC391472 813. Human monocyte-endothelial cell interaction in vitro. | *3865221* 3865221 | ||
814. Mechanisms of Vascular Calcification in Kidney Disease. | *31831120* 31831120 | ||
815. Weak-base induced lysosomal secretion by macrophages: an alternative trigger mechanism that is independent of complement activation. | *6818843* 6818843 | ||
816. Surgery of the parathyroid glands. | *4945299* 4945299 | ||
817. The pharmaco-cellular assessment of slow acting anti-inflammatory agents. | *4776364* 4776364 | ||
818. Relationship between exposure to asbestos, collagen formation, ferruginous bodies, and carcinoma. | *4372877* 4372877 | ||
819. Evaluation and management of the critically ill adult asthmatic in the emergency department setting. | *32222313* 32222313 | ||
820. Hypomagnesemia of unknown etiology. | *5923603* 5923603 | ||
821. Is antioxidant deficiency related to chronic obstructive pulmonary disease? | *3638136* 3638136 | ||
822. Alveolar macrophages: cell-free protein synthesis. | *5805270* 5805270 | ||
823. Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. | *3189965* 3189965 | ||
824. Inflammation-induced remote superactivity of macrophages. | *3729296* 3729296 | ||
825. Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis. | *32092762* 32092762 | ||
826. Penicillin neurotoxicity. | *4998180* 4998180 | ||
827. Oximetry-detected pulsus paradoxus predicts for severity in paediatric asthma. | *32094247* 32094247 | ||
828. Magnesium deficiency in bacteremic patients. | *3337602* 3337602 | ||
829. Pulmonary alveolar macrophage. Membrane associated sodium ion, potassium ion, and magnesium ion adenosine triphosphatase system. | *4252861* 4252861 | ||
830. The relationship of biochemical and histometric determinants of uremic bone. | *582255* 582255 | ||
831. The effect of some drugs on oxalic acid excretion in urine. | *4392557* 4392557 | ||
832. Electrophysiology of phagocytic membranes. Role of divalent cations in membrane hyperpolarizations of macrophage polykaryons. | *3955048* 3955048 | ||
833. Characteristics of the macrophage uptake of proteinase-alpha-macroglobulin complexes. | *58667* 58667 | ||
834. Quantitative studies of phagocytosis by alveolar macrophages. | *4726862* 4726862 | ||
835. Membrane transport in the rabbit alveolar macrophage. The specificity and characteristics of amino acid transport systems. | *5125243* 5125243 | ||
836. Magnesium and vitamin C supplementation attenuates steroid-associated osteonecrosis in a rat model. | *32045781* 32045781 | ||
837. Volatile anaesthetic for treatment of respiratory failure from status asthmaticus requiring extracorporeal membrane oxygenation. | *31948977* 31948977 | ||
838. Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies. | *4989288* 4989288 | ||
839. Immunoregulatory properties of some heavy metals in physiology and pathology conditions. Part I. | *3915874* 3915874 | ||
840. Influence of magnesium supplementation on bone turnover in the normal young mouse. | *6652550* 6652550 | ||
841. Intravenous hyperalimentation: a review. | *4997238* 4997238 | ||
842. The role of divalent cations in interactions between lymphokines and macrophages. | *6773670* 6773670 | ||
843. The mechanism of action of soluble lymphocytic mediators. II. Modification of macrophage migration and migration inhibitory factor action by drugs, enzymes and cationic environment. | *4376058* 4376058 | ||
844. Directional protrusive pseudopodial activity and motility in macrophages induced by extracellular electric fields. | *6816471* 6816471 | ||
845. Divalent cation requirements for mounting a respiratory burst in response to phorbol diesters by macrophages from SENCAR and C57BL/6 mice. | *3383281* 3383281 | ||
846. Outcome of status asthmaticus at a pediatric intensive care unit in Hong Kong. | *31965725* 31965725 | ||
847. Muscle and serum magnesium in pulmonary intensive care unit patients. | *3396369* 3396369 | ||
848. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. | *3956882* 3956882 | ||
849. Mechanisms of tobacco smoke toxicity on pulmonary macrophage cells. | *3862614* 3862614 | ||
850. Pharmacoprevention of tobacco smoke effects on macrophage cells. | *3862603* 3862603 | ||
851. Phorbol myristate acetate-induced macrophage aggregation. | *6403392* 6403392 | ||
852. Effects of cytochalasin B and of deoxyglucose on phagocytosis-related changes in membrane potential in rat peritoneal macrophages. | *6692862* 6692862 | ||
853. Macrophage spreading in vitro. I. Inducers of spreading. | *4570355* 4570355 | ||
854. Macrophage spreading in vitro. II. Manganese and other metals as inducers or as co-factors for induced spreading. | *4205701* 4205701 | ||
855. Amoeboid movements and cytoplasmic fragmentation of glycerinated leukocytes induced by ATP. | *4915188* 4915188 | ||
856. The dissociation of the attachment and ingestion phases of phagocytosis by macrophages. | *4960890* 4960890 | ||
857. Magnesium acetyltaurate protects against endothelin-1 induced RGC loss by reducing neuroinflammation in Sprague dawley rats. | *32156652* 32156652 | ||
858. Effect of divalent cations on cyclic AMP formation in human mononuclear leukocytes. | *6247196* 6247196 | ||
859. Experimental studies on the effects of heated chrysotile asbestos and automobile brake lining dust injected into the body cavities of mice. | *4763634* 4763634 | ||
860. Studies on the ultrastructural localization of adenosine triphosphatase activity in fracture callus. | *4267850* 4267850 | ||
861. Oxygen-dependent and oxygen-independent mechanisms of microbicidal activity of neutrophils. | *3910565* 3910565 | ||
862. Lymphokine-induced macrophage aggregation: studies on the involvement of Mg2+. | *6806210* 6806210 | ||
863. Blood mononuclear cell magnesium in normal pregnancy and preeclampsia. | *3584731* 3584731 | ||
864. Magnesium homeostasis during high-intensity anaerobic exercise in men. | *3558215* 3558215 | ||
865. Study of Serum Magnesium Level in COPD and its Impact on Exacerbation of COPD. | *31979802* 31979802 | ||
866. The calcium-buffering phase of bone mineral: some clues to its form and formation. | *3455165* 3455165 | ||
867. Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function. | *6822651* 6822651 | ||
868. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). | *6278021* 6278021 | ||
869. The activation of lymphocytes by the ionophore A 23 187. | *351052* 351052 | ||
870. Complement (C3)-activated phagocytosis by lung macrophages. | *641349* 641349 | ||
871. Receptors for immunoglobulin and complement on mouse leukemias and lymphomas. | *4340285* 4340285 | ||
872. The interaction of antigen with leucocytes of allergic individuals. | *4163009* 4163009 | ||
873. Serum magnesium and digitalis toxicity in chronic obstructive lung disease. | *521652* 521652 | ||
874. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. | *3525696* 3525696 | ||
875. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. | *6604771* 6604771 | ||
876. The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. | *6450254* 6450254 | ||
877. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. | *6422024* 6422024 | ||
878. Intravenous Magnesium in Asthma Pharmacotherapy: Variability in Use in the PECARN Registry. | *32147221* 32147221 | ||
879. Ionized calcium and magnesium: the effect of septic shock in the baboon. | *417190* 417190 | ||
880. The localization by electron microscopy of nucleoside phosphatase activity in guinea pig phagocytic cells. | *5956759* 5956759 | ||
881. Management of Acute Asthma in Adults in 2020. | *32044931* 32044931 | ||
882. Studies on the mechanism of phagocytosis. II. Analysis of the adhesion phase. | *4546927* 4546927 | ||
883. Magnesium prevents vascular calcification in Klotho deficiency. | *31866113* 31866113 | ||
884. Hypomagnesiamisches Koma wahrend Sepsistherapie bei akuter lymphatischer Leukamie-ein Fallbericht. | *6939939* 6939939 | ||
885. Pulmonary alveolar macrophage: demonstration of Na+ - K+, Mg++ ATPase activity. | *4243582* 4243582 | ||
886. Multifocal atrial tachycardia responsive to parenteral magnesium. | *3275209* 3275209 | ||
887. Magnesium and potassium status in healthy subjects as assessed by analysis of magnesium and potassium in skeletal muscle biopsies and magnesium in mononuclear cells. | *3573820* 3573820 | ||
888. Effect of calcitonin on the magnesium-induced bone resorption in the mouse. | *3573817* 3573817 | ||
889. Hypomagnesemia, hypocalcemia, and toxic-shock syndrome. A case report. | *3448408* 3448408 | ||
890. Bone magnesium in chronic obstructive pulmonary disease with hypercapnia. | *3928984* 3928984 | ||
891. Hydrogen inhibits the osteoclastogenesis of mouse bone marrow mononuclear cells. | *32204074* 32204074 | ||
892. Respiratory muscle failure. | *6341727* 6341727 | ||
893. Study on the action of olivine on macrophages "in vitro". | *4312406* 4312406 | ||
894. Effects of magnesium and lactose supplementation on bone metabolism in the X-linked hypophosphatemic mouse. | *6827987* 6827987 | ||
895. Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients. | *3211092* 3211092 | ||
896. Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. | *47148* 47148 | ||
897. Physiologic and pharmacologic regulation of bone resorption. | *4314044* 4314044 | ||
898. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. | *3277059* 3277059 | ||
899. Requirement for magnesium influx in activation of alveolar macrophages mediated by ionophore A23187. | *401955* 401955 | ||
900. Biochemical and morphological aspects of bone tissue in chronic renal failure. | *4842689* 4842689 | ||
901. The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes. | *32113793* 32113793 | ||
902. Endocrine manifestations of critical illness in the child. | *3543820* 3543820 | ||
903. Badania zachowania sie magnezu w surowicy i w krwinkach czerwonych u chorych na dychawice oskrzelowa. | *5029247* 5029247 | ||
904. Zachowanie sie magnezu w osoczu, krwinkach czerwonych i plwocinie u chorych z dychawica okrezelowa. | *5767980* 5767980 | ||
905. Mukopolisacharydy tkanki plucnej w stanach doswiadczalnej alergii. IV. Proba rozdzialu kwasnych MPS za pomoca roznych stezen soli magnezu. | *4228214* 4228214 | ||
906. Badanie magnezu w surowicy i krwinkach czerwonych u chorych na przewlekle choroby uklladu oddechowego. | *5028358* 5028358 | ||
907. The role of fibronectin in monocyte/macrophage function. | *6089231* 6089231 | ||
908. Platelet adhesion. | *6397767* 6397767 | ||
909. Trypsin as a potent activator of immune phagocytosis by macrophages. | *4799644* 4799644 | ||
910. On the pathogenesis of toxic shock syndrome. | *3317745* 3317745 | ||
911. Evaluation of magnesium status in Crohn's disease as assessed by intracellular analysis and intravenous magnesium infusion. | *3399827* 3399827 | ||
912. Magnesiumoxid als Ursache des Metallrauchfiebers. | *6879129* 6879129 | ||
913. Osobennosti obmena magniia u bol'nykh bronkhial'noi astmoi. | *601701* 601701 | ||
914. Hypokalsemi og hypomagnesemi ved meningokokksepsis. | *413209* 413209 | ||
915. Primenenie magniielektroforeza v kompleknoi terpaii bronkhial'noi astmy u detei. | *5610364* 5610364 | ||
916. Nekotorye pokazateli nespetsificheskogo immuniteta pri bronkhial'noi astme u detei. | *5996734* 5996734 | ||
917. Vurkhu obmianata na natrii, kalii, kaltsii i magnezii pri bolni s infektsiozno-alergichna bronkhialna astma. | *6730456* 6730456 | ||
918. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. | *8959161* 8959161 | ||
919. Why magnesium for asthma? | *8959159* 8959159 | ||
920. An ion for the lungs. | *8959158* 8959158 | ||
921. Management of asthma. | *7621174* 7621174 | ||
922. Intravenous magnesium sulphate in the management of refractory bronchospasm in a ventilated asthmatic. | *9291766* 9291766 | ||
PMC1061115 923. Effects of magnesium sulphate and nitric oxide in pulmonary hypertension induced by hypoxia in newborn piglets. | *7820707* 7820707 | ||
924. Effect of intravenous magnesium sulphate on airway calibre and airway reactivity to histamine in asthmatic subjects. | *8951195* 8951195 | ||
PMC1915847 925. Pyrimidinoceptor-mediated activation of phospholipase C and phospholipase A2 in RAW 264.7 macrophages. | *8886407* 8886407 | ||
PMC1170169 926. The Salmonella selC locus contains a pathogenicity island mediating intramacrophage survival. | *9311997* 9311997 | ||
PMC1566971 927. Pulmonary response to hyperoxia: effects of magnesium. | *7705282* 7705282 | ||
928. Stimulatory and inhibitory guanine-nucleotide-binding regulatory protein involvement in stimulation of arachidonic-acid release by N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor from guinea-pig alveolar macrophages. Differential receptor/G-protein interaction assessed by pertussis and cholera toxins. | *8386624* 8386624 | ||
929. Investigation of the effect of short-term change in dietary magnesium intake in asthma. | *9387944* 9387944 | ||
930. Skeletal muscle magnesium and potassium in asthmatics treated with oral beta 2-agonists. | *8777958* 8777958 | ||
PMC1457450 931. Cellular requirements for the formation of EA rosettes by human monocytes. | *738764* 738764 | ||
932. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. | *9556624* 9556624 | ||
933. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. | *9506997* 9506997 | ||
934. Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. | *9202042* 9202042 | ||
935. Analysis of macrophage surface receptors. I. Binding of alpha-macroglobulin . protease complexes to rabbit alveolar macrophages. | *88449* 88449 | ||
PMC2112800 936. Exocytosis of pinocytosed fluid in cultured cells: kinetic evidence for rapid turnover and compartmentation. | *7328118* 7328118 | ||
937. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. | *9133673* 9133673 | ||
PMC2191369 938. Separate metabolic pathways leading to DNA fragmentation and apoptotic chromatin condensation. | *8294867* 8294867 | ||
PMC2185888 939. Different divalent cation requirements for binding IgM complexes to lymphocytes and macrophages. | *7381365* 7381365 | ||
PMC2180591 940. Specific binding of soluble fibrin to macrophages. | *830791* 830791 | ||
PMC1295297 941. Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks. | *7562826* 7562826 | ||
PMC1758477 942. Bronchial reactivity and dietary antioxidants. | *9059479* 9059479 | ||
943. Multiple complications in severe diabetic ketoacidosis. A short review of the literature. | *821284* 821284 | ||
944. Health effect of occupational exposure to steady magnetic fields. | *6981340* 6981340 | ||
945. Usefulness of intravenous magnesium for multifocal atrial tachycardia in patients with chronic obstructive pulmonary disease. | *9462615* 9462615 | ||
946. Magnesium sulfate therapy in certain emergency conditions. | *9115526* 9115526 | ||
947. Magnesium and its therapeutic uses: a review. | *8304365* 8304365 | ||
948. Risk of magnesium for respiratory failure in pregnancy. | *9731870* 9731870 | ||
949. The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery. | *7065062* 7065062 | ||
950. Constitutive nitric oxide production by rat alveolar macrophages. | *9530171* 9530171 | ||
951. ATP- and UTP-induced currents in macrophages and macrophage polykaryons. | *7904123* 7904123 | ||
952. Chemically induced hypotension increases PGE2 release and depresses macrophage antigen presentation. | *8476108* 8476108 | ||
953. The assessment and management of adults with status asthmaticus. | *7735578* 7735578 | ||
954. Mononuclear blood cell magnesium in older subjects: evaluation of its use in clinical practice. | *8434863* 8434863 | ||
955. Refractory asthma, Part 1: Epidemiology, pathophysiology, pharmacologic interventions. | *9018193* 9018193 | ||
956. Intravenous magnesium for acute asthma. | *8442561* 8442561 | ||
957. Intravenous magnesium for acute asthma. | *8442560* 8442560 | ||
958. Intravenous magnesium for acute asthma. | *8442559* 8442559 | ||
959. Intravenous magnesium for acute asthma. | *8442558* 8442558 | ||
960. Intravenous magnesium for acute asthma. | *8442557* 8442557 | ||
961. Magnesium sulfate for the treatment of bronchospasm complicating acute bronchitis in a four-months'-pregnant woman. | *8333646* 8333646 | ||
962. Magnesium fortification of water. A possible step forward in preventive medicine? | *9538378* 9538378 | ||
963. The relation between magnesium, blood histamine level and eosinophilia in the acute stage of the allergic reactions in humans. | *749826* 749826 | ||
964. Nutrition and asthma. | *8996038* 8996038 | ||
965. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease. | *7864705* 7864705 | ||
966. Lack of effectiveness of magnesium in chronic stable asthma. A prospective, randomized, double-blind, placebo-controlled, crossover trial in normal subjects and in patients with chronic stable asthma. | *7832598* 7832598 | ||
967. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. | *9712695* 9712695 | ||
968. Magnesium measures across the menstrual cycle in premenstrual syndrome. | *8038300* 8038300 | ||
969. Continuous activation and deactivation of integrin CD11b/CD18 during de novo expression enables rolling neutrophils to immobilize on platelets. | *8652817* 8652817 | ||
970. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. | *8943853* 8943853 | ||
971. The role of apoptosis (programmed cell death) in haemopoiesis and the immune system. | *8467234* 8467234 | ||
972. Hypophosphataemia and hypokalaemia in patients with hypomagnesaemia. | *7841832* 7841832 | ||
973. Marked alterations in circulating inflammatory cells during cardiomyopathy development in a magnesium-deficient rat model. | *9389906* 9389906 | ||
974. Neuropathy in burn patients. | *8384917* 8384917 | ||
975. Effect of systemic zinc administration on delayed neuronal death in the gerbil hippocampus. | *9017270* 9017270 | ||
976. Ionized hypocalcemia in critically ill patients with sepsis. | *719567* 719567 | ||
977. Mechanisms of ATP-induced Ca2+ signaling in osteoclasts. | *7718410* 7718410 | ||
978. Magnesium saga. | *8625706* 8625706 | ||
979. Alternative pharmacotherapies for steroid-dependent asthma. | *7874959* 7874959 | ||
980. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. | *7781349* 7781349 | ||
981. Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline. | *8131528* 8131528 | ||
982. Diet as a risk factor for asthma. | *9257017* 9257017 | ||
983. Life-threatening asthma. | *7982342* 7982342 | ||
984. Magnesium and airway reactivity. | *9867444* 9867444 | ||
985. Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. | *9680494* 9680494 | ||
986. Acid-base and electrolyte abnormalities in febrile patients with bacteraemia. | *8258028* 8258028 | ||
987. Nutrition and cardiovascular disease. | *9182652* 9182652 | ||
988. Extracellular and intracellular magnesium concentrations in asthmatic patients. | *8224127* 8224127 | ||
989. Leucocyte locomotion and chemotaxis. The influence of divalent cations and cation ionophores. | *808419* 808419 | ||
990. Role of 1,25-dihydroxyvitamin D3 in the generation of the acute-phase response in rats with talc-induced granulomatosis. | *8359276* 8359276 | ||
991. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. | *8958131* 8958131 | ||
992. Medusa cells: cytostructure and cytochemistry of amoeboid eosinophils with pseudopod-like processes. | *7338480* 7338480 | ||
993. Chromatin changes in apoptosis. | *6975767* 6975767 | ||
994. Morphological, morphometric and x-ray microanalytical studies on lung tissue of rats exposed to chrysotile asbestos in inhalation chambres. | *7239646* 7239646 | ||
995. Human recombinant GM-CSF selectively primes receptor mediated respiratory burst of neutrophils in vitro. | *8300150* 8300150 | ||
996. Enhancement of phagocytosis by corticostatin I (CSI) in cultured mouse peritoneal macrophages. | *8956973* 8956973 | ||
997. Intravenous magnesium sulfate: a new weapon against acute asthma? | *9332128* 9332128 | ||
998. Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. | *9332112* 9332112 | ||
999. Role of nucleases in apoptosis. | *7981600* 7981600 | ||
1000. Medical and ventilatory management of status asthmaticus. | *9539066* 9539066 | ||
1001. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. | *7560484* 7560484 | ||
1002. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. | *8294630* 8294630 | ||
1003. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). | *7836621* 7836621 | ||
1004. Role of magnesium in regulation of lung function. | *8509592* 8509592 | ||
1005. Magnesium attenuates pulmonary hypertension due to hypoxia and group B streptococci. | *8002524* 8002524 | ||
1006. Magnesium in the management of asthma: critical review of acute and chronic treatments, and Deutsches Medizinisches Zentrum's (DMZ's) clinical experience at the Dead Sea. | *9777879* 9777879 | ||
1007. Effect of parenteral magnesium sulfate on pulmonary functions in bronchial asthma. | *8175629* 8175629 | ||
1008. Magnesium protects against anaphylactic shock and cardiac myolysis in guinea-pigs. | *8736070* 8736070 | ||
1009. Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin. | *8879258* 8879258 | ||
1010. Magnesium restriction induces granulocytic differentiation and expression of p27Kip1 in human leukemic HL-60 cells. | *9706868* 9706868 | ||
1011. Spontaneous and induced membrane hyperpolarizations in macrophages. | *811677* 811677 | ||
1012. Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fc alpha receptors or by complement receptors through different pathways. | *8786325* 8786325 | ||
1013. Preterm premature rupture of membranes: aggressive tocolysis versus expectant management. | *9502662* 9502662 | ||
1014. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. | *8969721* 8969721 | ||
1015. Interactions between fresh human blood monocytes and tumor targets at the single cell level: binding and morphological characteristics. | *6962303* 6962303 | ||
1016. The uptake of beryllium by the alveolar macrophage. | *7351651* 7351651 | ||
1017. Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. | *8231165* 8231165 | ||
1018. Effect of adenosine triphosphate-glucose administration following sepsis. | *7412271* 7412271 | ||
1019. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. | *7914305* 7914305 | ||
1020. Exacerbated immune stress response during experimental magnesium deficiency results from abnormal cell calcium homeostasis. | *9820125* 9820125 | ||
1021. Early morphological and immunological alterations in the spleen during magnesium deficiency in the rat. | *9800684* 9800684 | ||
1022. Effect of dietary magnesium on the susceptibility of mice to infection by protozoan parasites of the Apicomplexa and Mastigophora phyla. | *7547177* 7547177 | ||
1023. Triglyceride-rich lipoproteins from magnesium-deficient rats are more susceptible to oxidation by cells and promote proliferation of cultured vascular smooth muscle cells. | *7547176* 7547176 | ||
1024. Commentary on recent clinical advances: magnesium depletion, magnesium deficiency and asthma. | *8861139* 8861139 | ||
1025. Experimental and clinical effects of magnesium infusion in the treatment of neonatal pulmonary hypertension. | *8861137* 8861137 | ||
1026. Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion--the 'PKC syndrome'. | *8676754* 8676754 | ||
1027. Glucose loading induces DNA fragmentation in rat proximal tubular cells. | *8931638* 8931638 | ||
1028. Hypomagnesemia and smooth muscle contractility: diffuse esophageal spasm in an old female patient. | *9705572* 9705572 | ||
1029. Magnesium deficiency induces bone loss in the rat. | *9705567* 9705567 | ||
1030. The physicochemical structure of bone: cellular and noncellular elements. | *8202055* 8202055 | ||
1031. Leishmania donovani-macrophage binding mediated by surface glycoproteins/antigens: characterization in vitro by a radioisotopic assay. | *7322188* 7322188 | ||
1032. Rapid and sensitive PCR-based detection and differentiation of aetiologic agents of human granulocytotropic and monocytotropic ehrlichiosis. | *9633044* 9633044 | ||
1033. Use of magnesium sulfate in asthma in childhood. | *8643324* 8643324 | ||
1034. Safety and efficacy of magnesium sulfate infusions in children with status asthmaticus. | *7937295* 7937295 | ||
1035. Effects of ATP-magnesium chloride on the cardiopulmonary manifestations of group B streptococcal sepsis in the piglet. | *8848333* 8848333 | ||
1036. Opyt primeneniia induktotermii i magnii-elektroforeza v kompleksnom lechenii detei s ostrymi i khronicheskimi zabolevaniiami organov dykhaniia | *967616* 967616 | ||
1037. Serial changes of the plasma prostanoids during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitor. Prostaglandins Leukot Essent Fatty Acids 1997; 56 (2): 135-42 | *9051723* 9051723 | ||
1038. Rola magnezu w patogenezie i terapii astmy oskrzelowej. | *9501684* 9501684 | ||
1039. Le lavage broncho-alveolaire chez des mineurs d'uranium. | *7302347* 7302347 | ||
1040. Intravenous theophylline-induced excretion of calcium, magnesium and sodium in patients with recurrent asthmatic attacks. | *8197398* 8197398 | ||
1041. Protein kinase C activity is increased in rat heart during the early hyperdynamic phase of sepsis. | *9525327* 9525327 | ||
1042. Protein kinase a activity is increased in rat heart during late hypodynamic phase of sepsis. | *9249915* 9249915 | ||
1043. Narusheniia mineral'nogo metabolizma na razlichnykh etapakh razvitiia bronkhial'noi astmy. | *7482334* 7482334 | ||
1044. Rol' narushenii gomeostaza dvukhvalentnykh kationov v patogeneze i klinicheskoi kartine bronkhial'noi astmy. | *8202861* 8202861 | ||
1045. Ventilation of patients with asthma and obstructive lung disease. | *9891633* 9891633 | ||
1046. Struvite stones. | *9873215* 9873215 | ||
1047. Ob opredelenii bioelementov pri bronkhial'noi astme u detei | *995537* 995537 | ||
1048. The influence of CSF calcium and magnesium on the ventilatory response to carbon dioxide during hyperoxia. | *988552* 988552 | ||